Publications

Articles

Weir GC, Ehlers MR, Harris KM, Kanaparthi S, Long A, Phippard D, Weiner LJ, Jepson B, McNamara JG, Koulmanda M, Strom TB; ITN RETAIN Study Team. (2018). Alpha‐1 antitrypsin treatment of new‐onset type 1 diabetes: an open‐label, phase I clinical trial (RETAIN) to assess safety and pharmacokinetics. Pediatr Diabetes., E published ahead of print. http://dx.doi.org/10.1111/pedi.12660, PMID: 29473705

Feng S, Bucuvalas JC, Demetris AJ, Burrell BE, Spain KM, Kanaparthi S, Magee JC, Ikle D, Lesniak A, Lozano JJ, Alonso EM, Bray RA, Bridges NE, Doo E, Gebel HM, Gupta NA, Himes RW, Jackson AM, Lobritto SJ, Mazariegos GV, Ng VL, Rand EB, Sherker AH, Sundaram S, Turmelle YP, Sanchez-Fueyo A (2018). Evidence of Chronic Allograft Injury in Liver Biopsies From Long-term Pediatric Recipients of Liver Transplants. Gastroenterology, E published ahead of print. http://dx.doi.org/10.1053/j.gastro.2018.08.023, PMID: 30144432

John M. Wentworth, Naiara G. Bediaga, Lynne C. Giles, Mario Ehlers, Stephen E. Gitelman, Susan Geyer, Carmella Evans-Molina, Leonard C. Harrison, the Type 1 Diabetes TrialNet Study Group, the Immune Tolerance Network Study Group (2018). Beta cell function in type 1 diabetes determined from clinical and fasting biochemical variables. Diabetologia, Epub ahead of print, 1-8. http://dx.doi.org/10.1007/s00125-018-4722-z, PMID: 30167735

Santos AF, Couto-Francisco N, Becares N, Kwok M, Bahnson HT, Lack G (2018). A novel human mast cell activation test for peanut allergy. J Allergy Clin Immunol, 142 (2), 689-691. http://dx.doi.org/10.1016/j.jaci.2018.03.011, PMID: 29731128, PMCID: PMC6080741

Harris KM, Lu T, Lim N, Turka LA (2018). Challenges and Opportunities for Biomarkers of Clinical Response to AHSCT in Autoimmunity. Front Immunol, 2 (9), 100. http://dx.doi.org/10.3389/fimmu.2018.00100, PMID: 29456529, PMCID: PMC5801415

Savage, TM. Shonts, BA. Obradovic, A. Dewolf, S. Lau, S. Zuber, J. Simpson, MT. Berglund, E. Fu, J. Yang, S. Ho, S. Tang, Q. Turka, LA. Shen, Y. Sykes, M. (2018). Early expansion of donor-specific Tregs in tolerant kidney transplant recipients. JCI Insight, 3 (22). http://dx.doi.org/10.1172/jci.insight.124086, PMID: 30429370

Feng S, Demetris AJ, Kanaparthi S, Ekong UD, Alonso EM, Rosenthal P, Turka LA, Ikle D, Tchao NK, Spain KM, Burrell BE (2017). Five year histological and serological follow-up of operationally tolerant pediatric liver transplant recipients enrolled in WISP-R. Hepatology, 65 (2), 647-60. http://dx.doi.org/10.1002/hep.28681, PMID: 27302659, PMCID: PMC5159322

Khoury SJ, Ding L, Gao W, Arnold DL, Sayre PH, Smilek DE, Rochon J, Byron M, Ryker K, Tosta P, Freedman MS, ACCLAIM Study Group (2017). ACCLAIM: A randomized trial of abatacept (CTLA4-Ig) for relapsing-remitting multiple sclerosis. Mult Scler. http://dx.doi.org/10.1177/1352458516662727, PMID: 27481207, PMCID: PMC5288398

Wallace ZS, Miloslavsky EM, Cascino M, Unizony SH, Lu N, Hoffman GS, Kallenberg CG, Langford CA, Merkel PA, Monach PA, Seo P, Spiera R, St Clair EW, Specks U, Brunetta P, Choi HK, Stone JH (2017). Effect of Disease Activity, Glucocorticoid Exposure, and Rituximab Determine Body Composition Changes during Induction Treatment of ANCA-Associated Vasculitis. Arthritis Care Res (Hoboken)., 69 (7), 1001-10. http://dx.doi.org/10.1002/acr.23099, PMID: 27696762, PMCID: PMC5611860

Shaked A, Sayre P, Li YR, Asare S, DesMarais M, Holmes MV, Guettouche T, Keating BJ, Chang BL, Barnes MR (2017). An ectopically expressed serum miRNA signature is prognostic, diagnostic, and biologically related to liver allograft rejection. Hepatology, 65 (1), 269-80. http://dx.doi.org/10.1002/hep.28786, PMID: 27533743

Cartin-ceba R, Indrakanti D, Specks U, Stone JH, Hoffman GS, Kallenberg CG, Langford CA, Merkel PA, Spiera RF, Monach PA, Seo P, Tchao NK, Ytterberg SR, St Clair W, Brunetta PG, Song H, Birmingham D, Rovin BH; RAVE-ITN Research Group (2017). The pharmacogenomic association of Fcγ receptors and cytochrome p450 enzymes and response to treatment with rituximab or cyclophosphamide in Anti-Neutrophil Cytoplasmic Antibody-Associated vasculitis. Arthritis Rheumatol, 69 (1), 169-75. http://dx.doi.org/10.1002/art.39822, PMID: 27482943

Pepper RJ, Draibe JB, Fervenza FC, Hoffman GS, Kallenberg CG, Langford CA, Monach PA, Seo P, Spiera R, St Clair EW, Tchao NK, Stone JH, Specks U, Merkel PA, Caplin B, Salama AD; RAVE-ITN Research Group (2017). Association of serum calprotectin (S100A8/S100A9) levels with disease relapses in PR3-ANCA-associated vasculitis. Arthritis Rheumatol, 69 (1), 185-93. http://dx.doi.org/10.1002/art.39814, PMID: 27428710

Unizony S, Miloslavsky EM, Lu N, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, St Clair EW, Ikle D, Tchao NK, Ding L, Brunetta P, Monach PA, Fervenza F, Stone JH, Specks U; RAVE-ITN Research Group, Villarreal M, Kallenberg CM, Choi HK1 (2017). Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type. Ann Rheum Dis, 75 (6), 1166-9. http://dx.doi.org/10.1136/annrheumdis-2015-208073, PMID: 26621483, PMCID: PMC4908815

Scadding GW, Calderon MA, Shamji MH, Eifan AO, Penagos M, Sever ML, Bahnson HT, Lawson K, Harris KM, Lim N, Tchao NK, Togias A, Dumitru F, Plough AG, Panza JL, Qin T, Durham SR; Immune Tolerance Network GRASS Study Team (2017). Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical Trial. JAMA, 317 (6), 615-625. http://dx.doi.org/10.1001/jama.2016.21040, PMID: 28196255

Lim N, Brouard S, Harris KM, Ehlers MR, Gitelman SE, Soulillou JP, Salama A1, Evanno G, Rousse J, Le Berre L, Nicot A (2017). Anti-Gal and anti-Neu5Gc responses in nonimmunosuppressed patients following treatment with rabbit anti-thymocyte polyclonal IgGs. Transplantation, 101 (10), 2501-07. http://dx.doi.org/10.1097/TP.0000000000001686, PMID: 28198767

Nash RA, Hutton GJ, Racke MK, Popat U, Devine SM, Griffith LM, Muraro PA, Openshaw H, Sayre PH, Stüve O, Arnold DL, Georges GE, Wundes A, Kraft GH, Bowen JD, Steinmiller KC, Wener MH (2017). High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS. Neurology, Feb 1 2017. http://dx.doi.org/10.1212/WNL.0000000000003660, PMID: 28148635, PMCID: PMC5331868

Clain JM, Hummel AM, Stone JH, Fervenza FC, Hoffman GS, Kallenberg CG, Langford CA, Merkel PA, Monach PA, Seo P, Spiera RF, St Clair EW, Ytterberg SR, McCune WJ, Specks U; WGET and RAVE-ITN Research Groups (2017). Immunoglobulin (Ig)M antibodies to proteinase 3 in granulomatosis with polyangiitis and microscopic polyangiitis. Clin Exp Immunol, 188 (1), 174-81. http://dx.doi.org/0.1111/cei.12925, PMID: 28076879, PMCID: PMC5343341

Asare A, Kanaparthi S, Lim N, Phippard D, Burrell BE, Bridges N, Sanz I, Newell KA, Turka LA, Vincenti F, Friedewald J, Pavlakis M, Poggio E, Heeger P, Mannon R, Morrison Y, Chandraker A (2017). B Cell Receptor Genes Associated with Tolerance Identify a Cohort of Immunosuppressed Patients with Improved Renal Allograft Graft Function. Am J Transplant. http://dx.doi.org/10.1111/ajt.14283, PMID: 28371372, PMCID: PMC5620117

Sprangers B, DeWolf S, Morokata T, LoCascio SA, Shonts B, Zuber J, Morris H, Zorn E, Preffer FI, Dombkowski DM, Turka LA, Colvin R, Winchester R, Kawai T, Sykes M, Savage TM, Obradovic A, Lau SP, Shah R, Steshenko V, Olek S (2017). Origin of Enriched Regulatory T Cells in Patients Receiving Combined Kidney-Bone Marrow Transplantation to Induce Transplantation Tolerance. Am J Transplant. http://dx.doi.org/10.1111/ajt.14251, PMID: 28251801, PMCID: PMC5519438

Calatroni A, Liu AH, Gergen PJ, Gruchalla RS, Khurana Hershey GK, Kercsmar CM, Teach SJ, Wildfire JJ, Busse WW, Szefler SJ, Hoch HE, West JB, Kim H, Lamm C, Makhija MM, Mitchell HE (2017). Can we predict fall asthma exacerbations? Validation of the seasonal asthma exacerbation index. J Allergy Clin Immunol. http://dx.doi.org/10.1016/j.jaci.2017.01.026, PMID: 28238748, PMCID: PMC5568982

Danger R, Chesneau M, Paul C, Guérif P, Durand M, Newell KA, Kanaparthi S, Turka LA, Soulillou JP, Houlgatte R, Giral M, Ramstein G, Brouard S (2017). A composite score associated with spontaneous operational tolerance in kidney transplant recipients. Kidney Int, 91 (1), 1473-81. http://dx.doi.org/10.1016/j.kint.2016.12.020, PMID: 28242033, PMCID: PMC5432017

Esquivel A, Busse WW, Calatroni A, Togias AG, Grindle KG, Bochkov YA, Gruchalla RS, Kattan M, Kercsmar CM, Khurana Hershey G, Kim H, Lebeau P, Liu AH, Szefler SJ, Teach SJ, West JB, Wildfire J, Pongracic JA, Gern JE (2017). Effects of Omalizumab on Rhinovirus Infections, Illnesses and Exacerbations of Asthma. Am J Respir Crit Care Med, 196 (8), 985-92. http://dx.doi.org/10.1164/rccm.201701-0120OC, PMID: 28608756, PMCID: PMC5649984

Yang J, DeBerg HA, Speake C, Gersuk VH, Eddy JA, Reijonen H, Greenbaum CJ, Kwok WW, Gottardo R, Nepom GT, Linsley PS, Cerosaletti K, Barahmand-Pour-Whitman F, Dufort MJ, Murray SA, Israelsson E, Wambre E, Prlic M (2017). Single-Cell RNA Sequencing Reveals Expanded Clones of Islet Antigen-Reactive CD4+ T Cells in Peripheral Blood of Subjects with Type 1 Diabetes. J Immunol, 199 (1), 323-35. http://dx.doi.org/10.4049/jimmunol.1700172, PMID: 28566371, PMCID: PMC5499675

A Long, J Thorpe, KC Herold, M Ehlers, S Sanda, N Lim, PS Linsley, GT Nepom, KM Harris (2017). Remodeling T cell compartments during anti-CD3 immunotherapy of type 1 Diabetes. Cell Immunol. http://dx.doi.org/10.1016/j.cellimm.2017.07.007, PMID: 28844471, PMCID: PMC5614459

N Lim, DE Smilek, L Ding, SG Murray, B Diamond, D Wofsy (2017). Correlation of hypogammaglobulinaemia with proteinuria, and the relationship between hypogammaglobulinaemia and infection in active lupus nephritis. Lupus Sci Med, 4 (1). http://dx.doi.org/10.1136/lupus-2017-000229

Gill MA, Liu AH, Calatroni A, Gern JE, Togias A, Busse WW, Krouse RZ, Shao B, Schiltz A (2017). Enhanced plasmacytoid dendritic cell antiviral responses after omalizumab. J Allergy Clin Immunol. http://dx.doi.org/10.1016/j.jaci.2017.07.035, PMID: 28870461

Geetha D, Specks U, Kallenberg CGM, Lim N, Spiera R, St Clair EW, Merkel PA, Seo P, Monach PA, Fessler BJ, Langford CA, Hoffman GS, Stone JH, Sethi S, De Vriese AS, Lepori N, Sharma R, Fervenza FC; RAVE-ITN Research Group (2017). Interstitial Immunostaining and Renal Outcomes in Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis. Am J Nephrol. http://dx.doi.org/10.1159/000480443, PMID: 28881339

Keever-Taylor CA, Heimfeld S, Steinmiller KC, Nash RA, Sullivan KM, Czarniecki CW, Granderson TC, Goldstein JS, Griffith LM (2017). Manufacture of Autologous CD34+ Selected Grafts in the NIAID-Sponsored HALT-MS and SCOT Multicenter Clinical Trials for Autoimmune Diseases. Biol Blood Marrow Transplant, 23 (9), 1463-1472. http://dx.doi.org/10.1016/j.bbmt.2017.05.018, PMID: 28602891, PMCID: PMC5761325

Merkel PA, Monach PA, Carette S, Cuthbertson D, Hoffman GS, Langford CA, Specks U, Spiera RF, St Clair EW, Stone JH, Ytterberg SR, Xie G, Ji X, Ciavatta DJ, Byun J, Pinder BD, Zhao A, Zhang J, Tadesse Y, Qian D, Weirauch M, Nair R, Tsoi A, Pagnoux C, Chung S, Davis JC Jr, Dellaripa PF, Forbess L, Gewurz-Singer O, Khalidi N, Koening C, Mahr AD, McAlear C, Moreland L, Seo EP, Sreih A, Elder JT, Qu J, Ochi T, Hirano N, Edberg JC, Falk RJ, Amos CI, Siminovitch KA; Vasculitis Clinical Research Consortium (2017). Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis. Arthritis Rheumatol, 69 (5), 1054-66. http://dx.doi.org/10.1002/art.40034, PMID: 28029757, PMCID: PMC5434905

Du Toit G, Sayre PH, Roberts G, Lawson K, Sever ML, Bahnson HT, Fisher HR, Feeney M, Radulovic S, Basting M, Plaut M, Lack G; Immune Tolerance Network LEAP Study Team (2017). The allergen-specificity of early peanut consumption and the impact on the development of allergic disease in the LEAP Study Cohort. J Allergy Clin Immunol. http://dx.doi.org/10.1016/j.jaci.2017.09.034, PMID: 29097103

Greenhawt M, Fleischer DM, Chan ES, Venter C, Stukus D, Gupta R, Spergel JM (2017). LEAPing through the looking glass: secondary analysis of the effect of skin test size and age of introduction on peanut tolerance after early peanut introduction. Allergy, 72 (8), 1254-60. http://dx.doi.org/10.1111/all.13100, PMID: 27896827, PMCID: PMC5447487

Karnell FG, Lin D, Motley S, Duhen T, Lim N, Campbell DJ, Turka LA, Maecker HT, Harris KM (2017). Reconstitution of immune cell populations in multiple sclerosis patients after autologous stem cell transplantation. Clin Exp Immunol, 189 (3), 268-78. http://dx.doi.org/10.1111/cei.12985, PMID: 28498568, PMCID: PMC5543487

Shamji MH, Harris KM, Qin T, Wambre E, Scadding GW, Wurtzen PA, Till SJ, Togias A, Nepom GT, Kwok WW, Durham SR, Renand A (2017). Synchronous Immune Alterations Mirror Clinical Response During Allergen Immunotherapy. J Allergy Clin Immunol. , PMID: 29128670

Du Toit G, Plaut M, Lack G, Sampson H, Burks W, Akdis C (2017). Food Allergy: Update on Prevention and Tolerance. J Allergy Clin Immunol. http://dx.doi.org/10.1016/j.jaci.2017.11.010, PMID: 29191680

Sicherer SH, Sampson HA (2017). Food Allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention and management. J Allergy Clin Immunol. http://dx.doi.org/10.1016/j.jaci.2017.11.003, PMID: 29157945

Gao B1, Gu Y, Rong C, Moore C, Porcheray F, Wong W, Preffer F, Saidman Sl, Fu Y, Cosimi B, Sachs DH, Kawai T, Sykes M, Zorn E (2017). Dynamics of B Cell Recovery In Kidney/Bone Marrow Transplant Recipients. Transplantation, 101 (11), 2722-2730. http://dx.doi.org/10.1097/TP.0000000000001789, PMID: 28422925, PMCID: PMC5648631

Amon R, Ben-Arye SL, Engler L, Yu H, Lim N, Berre LL, Harris KM, Ehlers MR, Gitelman SE, Chen X, Soulillou JP, Padler-Karavani V (2017). Glycan microarray reveal induced IgGs repertoire shift against a dietary carbohydrate in response to rabbit anti-human thymocyte therapy. Oncotarget, 8 (68), 112236-112244. http://dx.doi.org/10.18632/oncotarget.23096, PMID: 29348821, PMCID: PMC5762506

Brennan DC, Kopetskie HA, Sayre PH, Alejandro R, Cagliero E, Shapiro AM, Goldstein JS, DesMarais MR, Booher S, Bianchine PJ (2016). Long-Term Follow-Up of the Edmonton Protocol of Islet Transplantation in the United States. Am J Transplant, 16 (2), 509-17. http://dx.doi.org/10.1111/ajt.13458, PMID: 26433206

Tooley JE, Vudattu N, Choi J, Cotsapas C, Devine L, Raddassi K, Ehlers MR, Harris KM, Kanaparthi S, Phippard D, Herold KC, McNamara JG (2016). Changes in T-cell subsets identify responders to FcR non-binding anti-CD3 mAb (teplizumab) in patients with Type 1 diabetes. Eur J Immunol, 46 (1), 230-41. http://dx.doi.org/10.1002/eji.201545708, PMID: 26518356, PMCID: PMC4882099

Pelletier D, Gao Z, Zamvil SS, Waubant E, Mowry EM, Howell MD (2016). Vitamin D in clinically isolated syndrome: evidence for possible neuroprotection. Eur J Neurol, 23 (2), 327-32. http://dx.doi.org/10.1111/ene.12844, PMID: 26518224

Hummel AM, Cartin-ceba R, Hoffman GS, Kallenberg CG, Langford CA, Merkel PA, Monach PA, Seo P, Spiera RF, St Clair EW, Tchao NK, Stone JH, Fussner LA, Schroeder DR, Silva F, Snyder MR, Specks U; RAVE-ITN Research Group. (2016). Factors Determining the Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3. Arthritis Rheumatol, 68 (7), 1700-10. http://dx.doi.org/10.1002/art.39637, PMID: 26882078

Gill RG, Pagni PP, Posgai A, Manenkova Y, Straub L, Bernstein P, Herold KC, von Herrath M, Staeva T, Ehlers MR, Nepom GT, Kufper T, Wasserfall CH, Deng S, Hani AB, Atkinson MA (2016). A Preclinical Consortium Approach for Assessing the Efficacy of Combined Anti-CD3 Plus IL-1 Blockade in Reversing New-Onset Autoimmune Diabetes in NOD Mice. Diabetes, 65 (5), 1310-16. http://dx.doi.org/10.2337/db15-0492, PMID: 26718498

Du Toit G, Sayre PH, Roberts G, Sever ML, Lawson K, Bahnson HT, Brough HA, Santos AF, Harris KM, Radulovic S, Basting M, Turcanu V, Plaut M, Lack G; Immune Tolerance Network LEAP-On Study Team (2016). Effect of Avoidance on Peanut Allergy after Early Peanut Consumption. N Engl J Med, 14 (374), 1435-43. http://dx.doi.org/10.1056/NEJMoa1514209, PMID: 26942922

Boyle KD, Keyes-Elstein L, Ehlers MR, McNamara J, Rigby MR, Gitelman SE, Herold KC, Weiner LJ, Much KL (2016). Two- and Four-Hour Tests Differ in Capture of C-Peptide Responses to a Mixed Meal in Type 1 Diabetes. Diabetes Care, 39 (6), e76-8. http://dx.doi.org/10.2337/dc15-2077, PMID: 27208317, PMCID: PMC4878222

Gitelman SE, Gottlieb PA, Felner EI, Willi SM, Fisher LK, Moran A, Gottschalk M, Moore WV, Pinckney A, Keyes-Elstein L, Harris KM, Kanaparthi S, Phippard D, Ding L, Bluestone JA, Ehlers MR; ITN START Study Team (2016). Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2 year results of a randomised trial. Diabetologia, 59 (6), 1153-61. http://dx.doi.org/10.1007/s00125-016-3917-4, PMID: 27053235, PMCID: PMC4869699

Pinckney A, Rigby MR, Keyes-Elstein L, Soppe CL, Nepom GT, Ehlers MR (2016). Correlation Among Hypoglycemia, Glycemic Variability, and C-Peptide Preservation After Alefacept Therapy in Patients with Type 1 Diabetes Mellitus: Analysis of Data from the Immune Tolerance Network T1DAL Trial. Clin Ther, 38 (6), 1327-39. http://dx.doi.org/10.1016/j.clinthera.2016.04.032, PMID: 27209482, PMCID: PMC4916002

Feeney M, Du Toit G, Roberts G, Sayre PH, Lawson K, Bahnson HT, Sever ML, Radulovic S, Plaut M, Lack G, Immune Tolerance Network LEAP Study Team (2016). Impact of peanut consumption in the LEAP Study: Feasibility, growth, and nutrition . J Allergy Clin Immunol, pii: S0091-6749 (16), 30262-7. http://dx.doi.org/10.1016/j.jaci.2016.04.016, PMID: 27297994, PMCID: PMC5056823

Galipeau J, Krampera M, Barrett J, Dazzi F, Deans RJ, DeBruijn J, Dominici M, Fibbe WE, Gee AP, Gimble JM, Hematti P, Koh MB, LeBlanc K, Martin I, McNiece IK, Mendicino M, Oh S, Ortiz L, Phinney DG, Planat V, Shi Y, Stroncek DF, Viswanathan S, Weiss DJ, Sensebe L (2016). International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials. Cytotherapy, 18 (2), 151-9. http://dx.doi.org/10.1016/j.jcyt.2015.11.008, PMID: 26724220, PMCID: PMC4745114

Long SA, Harris KM, Ehlers M, Herold KC, Nepom GT, Jerill Thorpe J, DeBerg HA, Gersuk V, Eddy JA, Linsley PS (2016). Partial exhaustion of CD8 T cells and clinical response to teplizumab in new-onset type 1 diabetes. Science Immunology, 1 (5), pii: eaai7793. http://dx.doi.org/10.1126/sciimmunol.aai7793, PMID: 28664195, PMCID: PMC5486405

Diamond B, Turka LA, Rosenberg AS, Pariser AR, Yao L, Lacana E, Kishnani PS (2016). A role for plasma cell targeting agents in immune tolerance induction in autoimmune disease and antibody responses to therapeutic proteins. Clin Immunol, 165 (April 2016), 55-9. http://dx.doi.org/10.1016/j.clim.2016.02.009, PMID: 26928739

Mathew JM, Levitsky J, Miller J, Leventhal JR, Salomon DR, Kurian SM, Friedewald JJ, Gallon L, Konieczna I, Tambur AR, Charette J, Jie C, Kanwar YS, Abecassis MM (2016). Nonchimeric HLA-Identical Renal Transplant Tolerance: Regulatory Immunophenotypic/Genomic Biomarkers. Am J Transplant, 16 (1), 221-34. http://dx.doi.org/10.1111/ajt.13416, PMID: 26227106, PMCID: PMC4718825

Miloslavsky EM, Lu N, Unizony S, Choi HK, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Tchao NK, Fervenza F, Monach PA, Specks U, Stone JH (2016). Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets. Arthritis Rheumatol, 68 (12), 2945-52. http://dx.doi.org/10.1002/art.39812, PMID: 27428559, PMCID: PMC5541999

Nash RA, Hutton GJ, Racke MK, Popat U, Devine SM, Griffith LM, Muraro PA, Openshaw H, Sayre PH, Stüve O, Arnold DL, Spychala ME, McConville KC, Harris KM, Phippard D, Georges GE, Wundes A, Kraft GH, Bowen JD (2015). High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): A 3-year interim report. JAMA Neurology, 72 (2), 159-69. http://dx.doi.org/10.1001/jamaneurol.2014.3780, PMID: 25546364, PMCID: PMC5261862

Morris H, DeWolf S, Robins H, Sprangers B, LoCascio SA, Shonts BA, Kawai T, Wong W, Yang S, Zuber J, Shen Y, Sykes M (2015). Tracking donor-reactive T cells: Evidence for clonal deletion in tolerant kidney transplant patients. Sci Transl Med, 7 (272), 272ra10. http://dx.doi.org/10.1126/scitranslmed.3010760, PMID: 25632034, PMCID: PMC4360892

Du Toit G, Roberts G, Sayre PH, Bahnson HT, Radulovic S, Santos AF, Brough HA, Phippard D, Basting M, Feeney M, Turcanu V, Sever ML, Gomez Lorenzo M, Plaut M, Lack G; LEAP Study Team (2015). Randomized trial of peanut consumption in infants at risk for peanut allergy. N Engl J Med, 372 (9), 803-813. http://dx.doi.org/10.1056/NEJMoa1414850, PMID: 25705822, PMCID: PMC4416404

Unizony S, Lim N, Phippard DJ, Carey VJ, Miloslavsky EM, Tchao NK, Ikle D, Asare AL, Merkel PA, Monach PA, Seo P, St Clair EW, Langford CA, Spiera R, Hoffman GS, Kallenberg CG, Specks U, Stone JH. (2015). Peripheral CD5+ B-cells in antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheumatol, 67 (2), 535-44. http://dx.doi.org/10.1002/art.38916, PMID: 25332071, PMCID: PMC4497572

Shamji MH, Bellido V, Scadding GW, Layhadi JA, Cheung DK, Calderon MA, Asare A, Gao Z, Turka LA, Tchao N, Togias A, Phippard D, Durham SR. (2015). Effector cell signature in peripheral blood following nasal allergen challenge in grass pollen allergic individuals. Allergy, 70 (2), 171-9. http://dx.doi.org/10.1111/all.12543, PMID: 25377909

Shamji MH, Layhadi JA, Scadding GW, Cheung DK, Calderon MA, Turka LA, Phippard D, Durham SR (2015). Basophil expression of diamine oxidase: a novel biomarker of allergen immunotherapy response. J Allergy Clin Immunol, 135 (4), 913-21. http://dx.doi.org/10.1016/j.jaci.2014.09.049, PMID: 25457150

Scadding GW, Eifan A, Penagos M, Dumitru A, Switzer A, McMahon O, Phippard D, Togias A, Durham SR, Shamji MH (2015). Local and systemic effects of cat allergen nasal provocation. Clin Exp Allergy, 45 (3), 613-23. http://dx.doi.org/10.1111/cea.12434, PMID: 25303516, PMCID: PMC4778413

Speake C, Presnell S, Domico K, Zeitner B, Bjork A, Anderson D, Mason MJ, Whalen E, Vargas O, Popov D, Rinchai D, Jourde-Chiche N, Chiche L, Quinn C, Chaussabel D (2015). An interactive web application for the dissemination of human systems immunology data. J Transl Med, 19 (13), 196. http://dx.doi.org/10.1186/s12967-015-0541-x, PMID: 26088622, PMCID: PMC4474328

Mark R. Rigby, Kristina M. Harris, Ashley Pinckney, Linda A. DiMeglio, Marc S. Rendell, Eric I. Felner, Jean M. Dostou, Stephen E. Gitelman, Kurt J. Griffin, Eva Tsalikian, Peter A. Gottlieb, Carla J. Greenbaum, Nicole A. Sherry, Wayne V. Moore, Roshanak Monzavi, Steven M. Willi, Philip Raskin, Lynette Keyes-Elstein, S. Alice Long, Sai Kanaparthi, Noha Lim, Deborah Phippard, Carol L. Soppe, Margret L. Fitzgibbon, James McNamara, Gerald T. Nepom, Mario R. Ehlers, and the Immune Tolerance Network (ITN) T1DAL Study Group (2015). Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients. J Clin Invest, 125 (8), 3285-96. http://dx.doi.org/10.1172/JCI81722, PMID: 26193635, PMCID: PMC4623571

Grayson PC, Carmona-Rivera C, Xu L, Lim N, Gao Z, Asare AL, Specks U, Stone JH, Seo P, Spiera RF, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Tchao NK, Ytterberg SR, Phippard DJ, Merkel PA, Kaplan MJ, Monach PA; Rituximab in ANCA-Associated Vasculitis-Immune Tolerance Network Research Group (2015). Neutrophil-Related Gene Expression and Low-Density Granulocytes Associated With Disease Activity and Response to Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Rheumatol, 67 (7), 1922-32. http://dx.doi.org/10.1002/art.39153, PMID: 25891759, PMCID: PMC4485551

Newell KA, Asare A, Sanz I, Wei C, Rosenberg A, Gao Z, Kanaparthi S, Asare S, Lim N, Stahly M, Howell M, Knechtle S, Kirk A, Marks WH, Kawai T, Spitzer T, Tolkoff-Rubin N, Sykes M, Sachs DH, Cosimi AB, Burlingham WJ, Phippard D, Turka LA (2015). Longitudinal Studies of a B Cell-Derived Signature of Tolerance in Renal Transplant Recipients. Am J Transplant, 15 (11), 2908-20. http://dx.doi.org/10.1111/ajt.13480, PMID: 26461968, PMCID: PMC4725587

Miloslavsky EM, Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Tchao NK, Ding L, Ikle D, Villareal M, Lim N, Brunetta P, Fervenza FC, Monach PA, Stone JH; Rituximab in ANCA-Associated Vasculitis-Immune Tolerance Network Research Group. (2015). Outcomes of nonsevere relapses in antineutrophil cytoplasmic antibody-associated vasculitis treated with glucocorticoids. Arthritis Rheumatol, 67 (6), 1629-36. http://dx.doi.org/10.1002/art.39104, PMID: 25776953

Geetha D, Specks U, Stone JH, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Fessler BJ, Ding L, Tchao NK, Ikle D, Jepson B, Brunetta P, Fervenza FC; Rituximab for ANCA-Associated Vasculitis Immune Tolerance Network Research Group. (2015). Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement. J Am Soc Nephrol, 26 (4), 796-85. http://dx.doi.org/10.1681/ASN.2014010046, PMID: 25381429, PMCID: PMC4378104

Burks AW, Wood RA, Jones SM, Scurlock AM, Vickery BP, Liu AH, Lindblad R, Plaut M, Sicherer SH, Fleischer DM, Henning AK, Dawson P, Sampson HA; Consortium of Food Allergy Research. (2015). Sublingual immunotherapy for peanut allergy: Long-term follow-up of a randomized multicenter trial. J Allergy Clin Immunol, 135 (5), 1240-8. http://dx.doi.org/10.1016/j.jaci.2014.12.1917, PMID: 25656999, PMCID: PMC4527157

Scadding GW, Penagos M, Switzer A, Phippard D, Togias A, Shamji MH, Durham SR, Eifan AO, Lao-Araya M, Poon SY, Steveling E, Yan R (2015). Effect of grass pollen immunotherapy on clinical and local immune response to nasal allergen challenge. Allergy, 70 (6), 689-96. http://dx.doi.org/10.1111/all.12608, PMID: 25773990, PMCID: PMC4826905

Speake C, Odegard JM (2015). Evaluation of Candidate Biomarkers of Type 1 Diabetes via the Core for Assay Validation. Biomark Insights, 10 (Suppl 4), 19-24. http://dx.doi.org/10.4137/BMI.S29697, PMID: 26462120, PMCID: PMC4589091

Fuchs EJ (2015). HLA-haploidentical blood or marrow transplantation with high-dose, post-transplantation cyclophosphamide. Bone Marrow Transplant, 50 (Suppl 2), S31-6. http://dx.doi.org/10.1038/bmt.2015.92, PMID: 26039204, PMCID: PMC4634886

Rosenthal P, Alonso EM, Ekong UD, Lobritto SJ, Feng S, Perito ER, Mohammad S (2015). Posttransplant Metabolic Syndrome in the Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients (WISP-R) Pilot Trial. Am J Transplant, 15 (3), 779-85. http://dx.doi.org/10.1111/ajt.13024, PMID: 25648649, PMCID: PMC4426259

Li YR, van Setten J, Verma SS, Lu Y, Holmes MV, Gao H, Lek M, Nair N, Chandrupatla H, Chang B, Karczewski KJ, Wong C, Mohebnasab M, Mukhtar E, Phillips R, Tragante V, Hou C, Steel L, Lee T, Garifallou J, Guettouche T, Cao H, Guan W, Himes A, van Houten J, Pasquier A, Yu R, Carrigan E, Miller MB, Schladt D, Akdere A, Gonzalez A, Llyod KM, McGinn D, Michaud Z, Colasacco A, Snyder J, Thomas K, Wang T, Wu B, Alzahrani AJ, Al-Ali AK, Al-Muhanna FA, Al-Rubaish AM, Al-Mueilo S, Monos DS, Murphy B, Olthoff KM, Wijmenga C, Webster T, Kamoun M, Balasubramanian S, Lanktree MB, Oetting WS, Garcia-Pavia P, MacArthur DG, Hakonarson H, Birdwell KA, Jacobson PA, Ritchie MD, Asselbergs FW, Israni AK, Shaked A, Keating BJ, Gangasan Ai, de Bakker PIW (2015). Concept and design of a genome-wide association genotyping array tailored for transplantation-specific studies. Genome Med, 7 (1), 90. http://dx.doi.org/10.1186/s13073-015-0211-x., PMID: 26423053, PMCID: PMC4589899

Holland CJ, Dolton G, Scurr M, Ladell K, Schauenburg AJ, Miners K, Madura F, Sewell AK, Price DA, Cole DK, Godkin AJ (2015). Enhanced Detection of Antigen-Specific CD4+ T Cells Using Altered Peptide Flanking Residue Peptide-MHC Class II Multimers. J Immunol, 195 (12), 5827-36. http://dx.doi.org/10.4049/jimmunol.1402787, PMID: 26553072, PMCID: PMC4671089

Rosenzwajg M, Churlaud G, Mallone R, Six A, Dérian N, Chaara W, Lorenzon R, Long SA, Buckner JH, Afonso G, Pham HP, Hartemann A, Yu A, Pugliese A, Malek TR, Klatzmann D (2015). Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients. J Autoimmun, Apr (58), 48-58. http://dx.doi.org/10.1016/j.jaut.2015.01.001, PMID: 25634360

International Genetics & Translational Research in Transplantation Network (iGeneTRAiN) (2015). Design and Implementation of the International Genetics and Translational Research in Transplantation Network. Transplantation, 99 (11), 2401-12. http://dx.doi.org/10.1097/TP.0000000000000913, PMID: 26479416, PMCID: PMC4623847

Teach SJ, Gill MA, Togias A, Sorkness CA, Arbes SJ Jr, Calatroni A, Wildfire JJ, Gergen PJ, Cohen RT, Pongracic JA, Kercsmar CM, Khurana Hershey GK, Gruchalla RS, Liu AH, Zoratti EM, Kattan M, Grindle KA, Gern JE, Busse WW, Szefler SJ1 (2015). Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations. J Allergy Clin Immunol, 136 (6), 1476-85. http://dx.doi.org/10.1016/j.jaci.2015.09.008, PMID: 26518090, PMCID: PMC4679705

Bluestone JA, Buckner JH, Gitelman SE, Herold KC, Long SA, Rieck M, Sayre PH, Tang Q, Fitch M, Gupta S, Hellerstein MK, Lares A, Lee MR, Li K, Liu W, Masiello LM, Nguyen V, Putnam AL (2015). Type 1 diabetes immunotherapy using polyclonal regulatory T cells. Sci Transl Med, 7 (315), 315ra189. http://dx.doi.org/10.1126/scitranslmed.aad4134, PMID: 26606968, PMCID: PMC4729454

Muraro PA, Robins H, Malhotra S, Howell M, Phippard D, Desmarais C, de Paula Alves Sousa A, Griffith LM, Lim N, Nash RA, Turka LA (2014). T cell repertoire following autologous stem cell transplantation for multiple sclerosis . J Clin Invest, 124 (3), 1168-72. http://dx.doi.org/10.1172/JCI71691, PMID: 24531550, PMCID: PMC3934160

Finak G, Jiang W, Krouse K, Wei C, Sanz I, Phippard D, Asare D, De Rosa SC, Self S, Gottardo R (2014). High-throughput flow cytometry data normalization for clinical trials. Cytometry A, 85 (3), 277-86. http://dx.doi.org/10.1002/cyto.a.22433, PMID: 24382714, PMCID: PMC3992339

Miloslavsky EM, Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St. Clair EW, Tchao NK, Viviano L, Ding L, Ikle D, Villareal M, Jepson B, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh K, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Stone JH; Rituximab in ANCA-Associated Vasculitis-Immune Tolerance Network Research Group (2014). Rituximab for the Treatment of Relapses in antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheumatol, 66 (11), 3151-59. http://dx.doi.org/10.1002/art.38788, PMID: 25047592, PMCID: PMC4229846

Vickery BP, Scurlock AM, Kulis M, Steele PH, Kamilaris J, Berglund JP, Burk C, Hiegel A, Carlisle S, Christie L, Perry TT, Pesek RD, Sheikh S, Virkud Y, Smith PB, Shamji MH, Durham SR, Jones SM, Burks AW (2014). Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy. J Allergy Clin Immunol, 133 (2), 468-75. http://dx.doi.org/10.1016/j.jaci.2013.11.007, PMID: 24361082, PMCID: PMC3960331

Wood RA, Togias A, Wildfire J, Visness CM, Matsui EC, Gruchalla R, Hershey G, Liu AH, O’Connor GT, Pongracic JA, Zoratti E, Little F, Granada M, Kennedy S, Durham SR, Shamji MH, Busse WW. (2014). Development of cockroach immunotherapy by the Inner-City Asthma Consortium. J Allergy Clin Immunol, 133 (3), 846-52. http://dx.doi.org/10.1016/j.jaci.2013.08.047, PMID: 24184147, PMCID: PMC3943647

Ang M, Meyer C, Brendel MD, Bretzel RG, Linn T (2014). Magnitude and mechanisms of glucose counterregulation following islet transplantation in patients with type 1 diabetes suffering from severe hypoglycaemic episodes. Diabetologia, 57 (3), 623-32. http://dx.doi.org/10.1007/s00125-013-3120-9, PMID: 24305963

The ACCESS Trial Group (2014). Treatment of lupus nephritis with abatacept: The Abatacept and Cyclophosphamide Combination Efficacy and Safety Study. Arthritis & Rheumatology, 66 (11), 3096-104. http://dx.doi.org/10.1002/art.38790, PMID: 25403681, PMCID: PMC4528976

Kawai T, Sachs DH, Sprangers B, Spitzer TR, Saidman Sl, Zorn E, Tolkoff-Rubin N, Preffer F, Crisalli K, Gao B, Wong W, Morris H, LoCascio SA, Sayre P, Shonts B, Williams WW, Colvin RB, Smith R-N, Sykes M, Cosimi AB. (2014). Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression. Am J Transplant, 14 (7), 1599-1611. http://dx.doi.org/10.1111/ajt.12731, PMID: 24903438, PMCID: PMC4228952

Sarikonda G, Sachithanantham S, Manenkova Y, Kupfer T, Posgai A, Wasserfall C, Bernstein P, Straub L, Pagni PP, Schneider D, Calvo TR, Coulombe M, Herold K, Gill RG, Atkinson M, Nepom G, Ehlers M, Staeva T, Garren H, Steinman L, Chan AC, von Herrath M (2013). Transient B-cell depletion with anti-CD20 in combination with proinsulin DNA vaccine or oral insulin: Immunologic effects and efficacy in NOD mice. PLoS One, 8 (2), e54712. http://dx.doi.org/10.1371/journal.pone.0054712, PMID: 23405091, PMCID: PMC3566105

Emerson R, Sherwood A, Desmarais C, Malhotra S, Phippard D, Robins H (2013). Estimating the ratio of CD4+ to CD8+ T cells using high-throughput sequence data. J Immunol Methods, 391 (1-2), 14-21. http://dx.doi.org/10.1016/j.jim.2013.02.002, PMID: 23428915

Herold KC, Gitelman SE, Ehlers MR, Gottlieb PA, Greenbaum CJ, Hagopian W, Boyle KD, Keyes-Elstein L, Aggarwal S, Phippard D, Sayre PH, McNamara J, Bluestone JA, the AbATE Study Team (2013). Teplizumab (anti-CD3 mAb) treatment preserves C-peptide responses in patients with new-onset type 1 diabetes in a randomized controlled trial: Metabolic and immunologic features at baseline identify a subgroup of responders. Diabetes, 62 (11), 3766-74. http://dx.doi.org/10.2337/db13-0345, PMID: 23835333, PMCID: PMC3806618

Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CGM, St. Clair EW, Fessler BJ, Ding L, Viviano L, Tchao NK, Phippard DJ, Asare AL, Lim N, Ikle D, Jepson B, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh K, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Mueller M, Sejismundo LP, Mieras K, Stone JH for the RAVE-ITN Research Group (2013). Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis. N Engl J Med, 369 (5), 417-27. http://dx.doi.org/10.1056/NEJMoa1213277, PMID: 23902481

Gitelman SE, Gottlieb PA, Rigby MR, Felner EI, Willi SM, Fisher LK, Moran A, Gottschalk M, Moore WV, Pinckney A, Keyes-Elstein L, Aggarwal S, Phippard D, Sayre PH, Ding L, Bluestone JA, Ehlers MR, the START Study Team (2013). Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial. Lancet Diabetes Endocrinol, 1 (4), 306-16. http://dx.doi.org/10.1016/S2213-8587(13)70065-2, PMID: 24622416

Rigby MR, DiMeglio LA, Rendell MS, Felner E, Dostou JM, Gitelman SE, Patel CM, Griffin KJ, Tsalikian E, Gottlieb PA, Greenbaum CJ, Sherry NA, Moore WV, Monzavi R, Willi SM, Raskin P, Moran A, Russell WE, Pinckney A, Keyes-Elstein L, Howell M, Aggarwal S, Lim N, Phippard D, Nepom GT, McNamara J, Ehlers MR, and the T1DAL Study Team (2013). Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Diabetes Endocrinol, 1 (4), 284-94. http://dx.doi.org/10.1016/S2213-8587(13)70111-6, PMID: 24622414, PMCID: PMC3957186

Miloslavsky EM, Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CGM, St. Clair EW, Tchao NK, Viviano L, Ding L, Sejismundo LP, Mieras K, Ikle D, Jepson B, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh K, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Stone JH, for the Rituximab in ANCA-Associated Vasculitis-Immune Tolerance Network Research Group (2013). Clinical Outcomes of Remission Induction Therapy for Severe Antineutrophil Cytoplasmic Antibody–Associated Vasculitis. Arthritis Rheum, 65 (9), 2441-9. http://dx.doi.org/10.1002/art.38044, PMID: 23754238, PMCID: PMC4949954

Yu L, Dong F, Miao D, Fouts AR, Wenzlau JM, Steck AK (2013). Proinsulin/insulin autoantibodies measured with electrochemiluminescent assay are the earliest indicator of prediabetic islet autoimmunity. Diabetes Care, 36 (8), 2266-70. http://dx.doi.org/10.2337/dc12-2245, PMID: 23423694, PMCID: PMC3714529

Isse K, Lesniak A, Grama K, Maier J, Specht S, Castillo-Rama M, Lunz J, Roysam B, Michalopoulos G, Demetris AJ (2013). Pre-existing epithelial diversity in normal human livers: A tissue-tethered cytometric analysis in portal/periportal epithelial cells. Hepatology, 57 (4), 1632-43. http://dx.doi.org/10.1002/hep.26131, PMID: 23150208, PMCID: PMC3612393

Nelson EK, Piehler B, Rauch A, Ramsay S, Holman D, Asare S, Asare A, Igra M (2013). Ancillary study management systems: a review of needs. BMC Med Inform Decis Mak, 13 (5), 1-17. http://dx.doi.org/10.1186/1472-6947-13-5, PMID: 23294514, PMCID: PMC3564696

Feng S, Ekong UD, Lobritto SJ, Demetris AJ, Roberts JP, Rosenthal P, Alonso EM, Philogene MC, Ikle D, Poole KM, Bridges ND, Turka LA, Tchao NK (2012). Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants. JAMA, 307 (3), 283-93. http://dx.doi.org/10.1001/jama.2011.2014, PMID: 22253395

Monach PA, Kumpers P, Lukasz A, Tomasson G, Specks U, Stone JH, Cuthbertson D, Krischer J, Carette S, Ding L, Hoffman GS, Ikle D, Kallenberg CG, Khalidi NA, Langford CA, Seo P, St. Clair EW, Spiera R, Tchao N, Ytterberg SR, Haubitz M, Merkel PA (2012). Circulating angiopoietin-2 as a biomarker in ANCA-associated Vasculitis. PLoS One, 7 (1), e30197. http://dx.doi.org/10.1371/journal.pone.0030197, PMID: 22279570, PMCID: 3261176

Waubant E, Pelletier D, Mass M, Cohen JA, Kita M, Cross A, Bar-Or A, Vollmer T, Racke M, Stüve O, Schwid S, Goodman A, Kachuck N, Preiningerova J, Weinstock-Guttman B, Calabresi PA, Miller A, Mokhtarani M, Ikle D, Murphy S, Kopetskie H, Ding L, Rosenberg E, Spencer C, Zamvil SS, ITN020AI Study Management Team, ITN STAyCIS Study Group (2012). Randomized controlled trial of atorvastatin in clinically isolated syndrome. Neurology, 78 (15), 1171-8. http://dx.doi.org/10.1212/WNL.0b013e31824f7fdd, PMID: 22459680, PMCID: PMC3320055

Long SA, Rieck M, Sanda S, Bollyky JB, Samuels PL, Goland R, Ahmann A, Rabinovitch A, Aggarwal S, Phippard D, Turka LA, Ehlers MR, Bianchine PJ, Boyle KD, Adah SA, Bluestone JA, Buckner JH, Greenbaum CJ, Diabetes TrialNet and the Immune Tolerance Network (2012). Rapamycin/IL-2 combination therapy in Type 1 Diabetes. Diabetes, 61 (9), 2340-8. , PMID: 22721971, PMCID: PMC3425404

Scadding GW, Calderon MA, Bellido V, Koed GK, Nielsen NC, Lund K, Togias A, Phippard D, Turka LA, Hansel TT, Durham SR, Wurtzen PA (2012). Optimisation of grass pollen nasal allergen challenge for assessment of clinical and immunological outcomes. J Immunol Methods, 384 (1-2), 25-31. , PMID: 22759401

Du Toit G, Roberts G, Sayre PH, Plaut M, Bahnson HT, Mitchell H, Radulovic S, Chan S, Fox A, Turcanu V, Lack G (2012). Identifying infants at high risk of peanut allergy: The Learning Early About Peanut Allergy (LEAP) screening study. J Allergy Clin Immunol, 131 (1), 135-143. , PMID: 23174658

Finak G, Jiang W, Pardo J, Asare A, Gottardo R (2012). QUAliFiER: An automated pipeline for quality assessment of gated flow cytometry data. BMC Bioinformatics, Sep (13), 252. , PMID: 23020243, PMCID: 3499158

Shamji MH, Ljorring C, Francis JN, Calderon MA, Larché M, Kimber I, Frew AJ, Ipsen H, Lund K, Wurtzen PA, Durham SR (2012). Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapy. Allergy, 62 (2), 217-26. http://dx.doi.org/10.1111/j.1398-9995.2011.02745.x, PMID: 22077562

Haynes LD, Jankowska-Gan E, Sheka A, Keller MR, Hernandez-Fuentes MP, Lechler RI, Seyfert-Margolis V, Turka LA, Newell KA, Burlingham WJ (2012). Donor-specific indirect pathway analysis reveals a B-cell-independent signature which reflects outcomes in kidney transplant recipients. Am J Transplant., 12 (3), 640-8. http://dx.doi.org/10.1111/j.1600-6143.2011.03869, PMID: 22151236, PMCID: PMC3374729

James LK, Shamji MH, Walker SM, Wilson DR, Wachholz PA, Francis JN, Jacobson MR, Kimber I, Till SJ, Durham, SR (2011). Long term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies. J Allergy Clin Immunol, 127 (2), 509-16. http://dx.doi.org/10.1016/j.jaci.2010.12.1080, PMID: 21281875

Farris AB, Taheri D, Kawai T, Fazlollahi L, Wong W, Tolkoff-Rubin N, Spitzer TR, Iafrate AJ, Preffer FI, LoCascio SA, Sprangers B, Saidman S, Smith RN, Cosimi AB, Sykes M, Sachs DH, Colvin RB (2011). Acute renal endothelial injury during marrow recovery in a cohort of combined kidney and bone marrow allografts. Am J Transplant, 11 (7), 1464-77. http://dx.doi.org/10.1111/j.1600-6143.2011.03572.x, PMID: 21668634, PMCID: PMC3128680

Radassi K, Kent SC, Yang J, Bourcier K, Bradshaw EM, Seyfert-Margolis V, Nepom GT, Kwok WW, Hafler DA (2011). Increased frequencies of myelin oligodendrocyte glycoprotein/MHC Class II-binding CD4 cells in patients with multiple sclerosis. J Immunol, 187 (2), 1039-46. http://dx.doi.org/10.4049/jimmunol.1001543, PMID: 21653833, PMCID: PMC3131477

Specks U, Merkel PA, Hoffman GS, Langford CA, Spiera R, Seo P, Kallenberg CGM, St. Clair EW, Ding L, Webber L, Mokhtarani M, Tchao NK, Sayre PH, Seyfert-Margolis V, Ikle D, Brunetta P, Zhang D, Sejismundo L, Mueller M, Stone JH (2011). Design of the Rituximab in ANCA-associated Vasculitis (RAVE) Trial. The Open Arthritis Journal, 4 (1), 1-18.

Monach PA, Tomasson G, Specks U, Stone JH, Cuthbertson D, Krischer J, Ding L, Fervenza FC, Fessler BJ, Hoffman GS, Ikle D, Kallenberg CG, Langford CA, Mueller M, Seo P, St. Clair EW, Spiera R, Tchao N, Ytterberg SR, Gu YZ, Snyder RD, Merkel PA (2011). Circulating markers of vascular injury and angiogenesis in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Rheum, 36 (12), 3988-97. http://dx.doi.org/10.1002/art.30615, PMID: 21953143, PMCID: PMC3227746

Strober S, Spitzer TR, Lowsky R, Sykes M (2011). Translational studies in hematopoietic cell transplantation: treatment of hematologic malignancies as a stepping stone to tolerance induction. Semin Immunol, 23 (4), 273-81. http://dx.doi.org/10.1016/j.smim.2011.05.001, PMID: 21705229, PMCID: PMC3201788

Sachs DH, Sykes M, Kawai T, Cosimi AB (2011). Immuno-intervention for the induction of transplantation tolerance through mixed chimerism. Semin Immunol, 23 (3), 165-73. http://dx.doi.org/10.1016/j.smim.2011.07.001, PMID: 21839648, PMCID: PMC3178004

Andreola G, Chittenden M, Shaffer J, Cosimi AB, Kawai T, Cotter P, LoCascio SA, Morokata T, Dey BR, Tolkoff-Rubin NT, Preffer F, Bonnefoix T, Kattleman K, Spitzer TR, Sachs DH, Sykes M (2011). Mechanisms of donor-specific tolerance in recipients of haploidentical combined bone marrow/kidney transplantation. Am J Transplant, 11 (6), 1236-47. http://dx.doi.org/10.1111/j.1600-6143.2011.03566.x, PMID: 21645255, PMCID: PMC3140222

Spitzer TR, Sykes M, Tolkoff-Rubin N, Kawai T, McAfee SL, Dey BR, Ballen K, Delmonico F, Saidman S, Sachs DH, Cosimi AB (2011). Long-term follow-up of recipients of combined human leukocyte antigen-matched bone marrow and kidney transplantation for multiple myeloma with end-stage renal disease. Transplantation, 91 (6), 672-6. http://dx.doi.org/10.1097/TP.0b013e31820a3068, PMID: 21217460, PMCID: PMC3232059

Hahne F, Khodabakhshi AH, Bashashati A, Wong CJ, Gascoyne RD, Weng AP, Seyfert-Margolis V, Bourcier K, Asare A, Lumley T, Gentleman R, Brinkman RR (2010). Per-channel basis normalization methods for flow cytometry data. Cytometry A, 77 (2), 121-31. http://dx.doi.org/10.1002/cyto.a.20823, PMID: 19899135, PMCID: PMC3648208

Newell KA, Asare A, Kirk AD, Gisler TD, Bourcier K, Suthanthiran M, Burlingham WJ, Marks WH, Sanz I, Lechler RI, Hernandez-Fuentes MP, Turka LA, Seyfert-Margolis VL (2010). Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest, 120 (6), 1836-47. http://dx.doi.org/10.1172/JCI39933, PMID: 20501946, PMCID: PMC2877933

Sagoo P, Perucha E, Sawitzki B, Tomiuk S, Stephens DA, Miqueu P, Chapman S, Craciun L, Sergeant R, Brouard S, Rovis F, Jimenez E, Ballow A, Giral M, Rebollo-Mesa I, Le Moine A, Braudeau C, Hilton R, Gerstmayer B, Bourcier K, Sharif A, Krajewska M, Lord GM, Roberts I, Goldman M, Wood KJ, Newell K, Seyfert-Margolis V, Warrens AN, Janssen U, Volk HD, Soulillou JP, Hernandez-Fuentes MP, Lechler RI (2010). Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest, 120 (6), 1848-61. http://dx.doi.org/10.1172/JCI39922, PMID: 20501943, PMCID: PMC2877932

Orban T, Farkas K, Jalahej H, Kis J, Treszl A, Falk B, Reijonen H, Wolfsdorf J, Ricker A, Matthews JB, Tchao N, Sayre P, Bianchine P (2010). Autoantigen-specific regulatory T cells induced in patients with type 1 diabetes mellitus by insulin B-chain immunotherapy. J Autoimmun, 34 (4), 408-15. http://dx.doi.org/10.1016/j.jaut.2009.10.005, PMID: 19931408, PMCID: PMC2860016

Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CG, St. Clair EW, Turkiewicz A, Tchao NK, Webber L, Ding L, Sejismundo LP, Mieras K, Weitzenkamp D, Ikle D, Seyfert-Margolis V, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh KA, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Specks U, RAVE-ITN Research Group (2010). Rituximab versus cyclophosphamide for ANCA-associated vasculitis. New Eng J Med, 363 (3), 221-32. http://dx.doi.org/10.1056/NEJMoa090990, PMID: 20647199, PMCID: PMC3137658

LoCascio SA, Morokata T, Chittenden M, Preffer FI, Dombkowski DM, Andreola G, Crisalli K, Kawai T, Saidman Sl, Spitzer TR, Tolkoff-Rubin N, Cosimi BA, Sachs DH, Sykes M (2010). Mixed chimerism, lymphocyte recovery, and evidence for early donor-specific unresponsiveness in patients receiving combined kidney and bone marrow transplantation to induce tolerance. Transplantation, 90 (12), 1607-15. http://dx.doi.org/10.1097/TP.0b013e3181ffbaff, PMID: 21085064, PMCID: PMC3059844

Grant J, Bourcier K, Wallace S, Pan D, Conway A, Seyfert-Margolis V, Wallace PK (2009). Validated protocol for FoxP3 reveals increased expression in type 1 diabetes patients. Cytometry B Clin Cytom, 72 (2), 69-78. http://dx.doi.org/10.1002/cyto.b.20446, PMID: 18690669

Asare A, Gao Z, Carey VJ, Wang R, Seyfert-Margolis V (2009). Power enhancement via multivariate outlier testing with gene expression arrays. Bioinformatics, 25 (1), 48-53. http://dx.doi.org/10.1093/bioinformatics/btn591, PMID: 19015138, PMCID: PMC2638936

Shankar RD, Martins SB, O'Connor MJ, Parrish DB, Das AK (2009). Representing and Reasoning with Temporal Constraints in Clinical Trials Using Semantic Technologies. Biomedical Engineering Systems and Technologies Springer Berlin Heidelberg, Apr (78), Suppl 1:S77-85. http://dx.doi.org/10.1016/j.ijmedinf.2008.07.013, PMID: 18789876

Knechtle SJ, Pascual J, Bloom DD, Torrealba JR, Jankowska-Gan E, Burlingham WJ, Kwun J, Colvin RB, Seyfert-Margolis V, Bourcier K, Sollinger HW (2009). Early and limited use of tacrolimus to avoid rejection in an alemtuzumab and sirolimus regimen for kidney transplantation: clinical results and immune monitoring. Am J Transplant, 9 (5), 1087-98. http://dx.doi.org/10.1111/j.1600-6143.2009.02581.x, PMID: 19344431

Herold KC, Gitelman S, Greenbaum C, Puck J, Hagopian W, Gottlieb P, Sayre P, Bianchine P, Wong E, Seyfert-Margolis V, Bourcier K, Bluestone JA, ImmuneTolerance Network ITN007AI Study Group (2009). Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb Teplizumab preserves insulin production for up to 5 years. Clin Immunol, 132 (2), 166-73. http://dx.doi.org/10.1016/j.clim.2009.04.007, PMID: 19443276, PMCID: PMC2735402

Yu J, Steck AK, Babu S, Yu L, Miao D, McFann K, Hutton J, Eisenbarth GS, Klingensmith G (2009). Single nucleotide transcription factor 7-like 2 (TCF7L2) gene polymorphisms in antiislet autoantibody-negative patients at onset of diabetes. J Clin Endocrinol Metab, 94 (2), 504-10. http://dx.doi.org/10.1210/jc.2007-2694, PMID: 19050058, PMCID: PMC2646512

Babaya N, Liu E, Miao D, Li M, Yu L, Eisenbarth GS (2009). Murine high specificity/sensitivity competitive europium insulin autoantibody assay. Diabetes Technol Ther, 11 (4), 227-33. http://dx.doi.org/10.1089/dia.2008.0072, PMID: 19344197, PMCID: PMC2903340

de Jager W, Bourcier K, Rijkers GT, Prakken BJ, Seyfert-Margolis V (2009). Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays. BMC Immunol, 28 (10), 52. http://dx.doi.org/10.1186/1471-2172-10-52, PMID: 19785746, PMCID: PMC2761376

Porcheray F, Wong W, Saidman Sl, De Vito J, Girouard TC, Chittenden M, Shaffer J, Tolkoff-Rubin N, Dey BR, Spitzer TR, Colvin RB, Cosimi AB, Kawai T, Sachs DH, Sykes M, Zorn E (2009). B-cell immunity in the context of T-cell tolerance after combined kidney and bone marrow transplantation in humans. Am J Transplant, 9 (9), 2126-35. http://dx.doi.org/10.1111/j.1600-6143.2009.02738.x, PMID: 19624570, PMCID: PMC2837587

Kawai, T, Cosimi AB, Spitzer TR, Tolkoff-Rubin, N, Suthanthiran M, Saidman Sl, Shaffer J, Preffer FI, Ding R, Sharma V, Fishman JA, Dey B, Ko DSC, Hertl M, Goes NB, Wong W, Williams WW, Colvin RB, Sykes M, Sachs DH (2008). HLA-Mismatched renal transplantation without maintenance immunosuppression. N Engl J Med, 358 (4), 353-61. http://dx.doi.org/10.1056/NEJMoa071074, PMID: 18216355, PMCID: PMC2819046

Viglietta V, Bourcier K, Buckle GJ, Healy B, Weiner HL, Hafler DA, Egorova S, Guttmann CRG, Rusche JR, Khoury SJ (2008). CTLA4Ig treatment in patients with multiple sclerosis: an open-label, phase 1 clinical trial. Neurology, 71 (12), 917-24. http://dx.doi.org/10.1212/01.wnl.0000325915.00112.61, PMID: 18794494

Francis JN, James LK, Paraskevopoulos G, Wong C, Calderon MA, Durham SR, Till SJ (2008). Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity. J Allergy Clin Immunol, 121 (5), 1120-5. http://dx.doi.org/10.1016/j.jaci.2008.01.072, PMID: 18374405

Srikantha M, Sergeant R, Khan T, Lechler RI, Davey N, Hernandez-Fuentes MP, Warrens AN (2008). Retrospective tissue typeing of the kidney donor from recipient urine. Kidney Int, 74 (7), 952-5. http://dx.doi.org/10.1038/ki.2008.340, PMID: 18633344

O'Connor MJ, Shankar RD, Parrish DB, Das AK (2008). Knowledge-data integration for temporal reasoning in a clinical trial system. Int J Med Inform, 78 (1), S77-85. http://dx.doi.org/10.1016/j.ijmedinf.2008.07.013, PMID: 18789876

Lee JA, Spidlen J, Boyce K, Cai J, Crosbie N, Dalphin M, Furlong J, Gasparetto M, Goldberg M, Goralczyk EM, Hyun B, Jansen K, Kollmann T, Kong M, Leif R, McWeeney S, Moloshok TD, Moore W, Nolan G, Nolan J, Nikolich-Zugich J, Parrish D, Purcell B, Qian Y, Selvaraj B, Smith C, Tchuvatkina O, Wertheimer A, Wilkinson P, Wilson C, Wood J, Zigon R; International Society for Advancement of Cytometry Data Standards Task Force, Scheuermann RH, Brinkman RR (2008). MIFlowCyt: the minimum information about a Flow Cytometry Experiment. Cytometry, 73 (10), 926-30. http://dx.doi.org/10.1002/cyto.a.20623, PMID: 18752282, PMCID: PMC2773297

Asare AL, Kolchinsky SA, Gao Z, Wang R, Raddassi K, Bourcier K, Seyfert-Margolis V (2008). Differential gene expression profiles are dependent upon method of peripheral blood collection and RNA isolation. BMC Genomics, 10 (9), 474. http://dx.doi.org/10.1186/1471-2164-9-474, PMID: 18847473, PMCID: PMC2573897

Feng S (2008). Long-term management of immunosuppression after pediatric liver transplantation: is minimization or withdrawal desirable or possible or both?. Curr Opin Organ Transplant, 13 (5), 506-12. http://dx.doi.org/10.1097/MOT.0b013e328310b0f7, PMID: 19060534, PMCID: PMC2727645

Levesque MC, St Clair EW. (2008). B cell-directed therapies for autoimmune disease and correlates of disease response and relapse. J Allergy Clin Immunol, 121 (1), 13-21. http://dx.doi.org/10.1016/j.jaci.2007.11.030, PMID: 18206502

Xu Q, Lee J, Jankowska-Gan E, Schultz J, Roennburg DA, Haynes LD, Kusaka S, Sollinger HW, Knechtle SJ, Vanbuskirk AM, Torrealba JR, Burlingham WJ (2007). Human CD4+CD25low Adaptive T Regulatory Cells Suppress Delayed-Type Hypersensitivity during Transplant Tolerance. J Immunol, 178 (6), 3983-95. , PMID: 17339499

Derks RA, Jankowska-Gan E, Xu Q, Burlingham WJ (2007). Dendritic cell type determines the mechanism of bystander suppression by adaptive T regulatory cells specific for the minor antigen HA-1. J Immunol, 179 (6), 3443-51. , PMID: 17785778

Klunker S, Saggar LR, Seyfert-Margolis V, Asare AL, Casale TB, Durham SR, Francis JN, Immune Tolerance Network Group (2007). Combination treatment with omalizumab and rush immunotherapy for ragweed-induced allergic rhinitis: Inhibition of IgE-facilitated allergen binding. J Allergy Clin Immunol, 120 (3), 688-95. , PMID: 17631952

Baschal EE, Aly TA, Babu SR, Fernando MS, Yu L, Miao D, Barriga KJ, Norris JM, Noble JA, Erlich HA, Rewers MJ, Eisenbarth GS (2007). HLA-DPB1*0402 protects against type 1A diabetes autoimmunity in the highest risk DR3-DQB1*0201/DR4DQB1*0302 DAISY population. Diabetes, 56 (9), 2405-2409. , PMID: 17513705

Liu E, Eisenbarth GS (2007). Accepting clocks that tell time poorly: fluid-phase versus standard ELISA autoantibody assays. Clin Immunol, 125 (2), 120-126. , PMID: 17904423, PMCID: PMC2104491

Wang J, Miao D, Babu S, Yu J, Barker J, Klingensmith G, Rewers M, Eisenbarth GS, Yu L (2007). Prevelence of autoantibody-negative diabetes is not rare at all ages and increases with older age and obesity. J Clin Endocrinol, 92 (1), 88-92. , PMID: 17062766

Yu L, Wang J, O'Dell JR, Oates J, Arend WP, Eisenbarth GS (2007). Anti-dsDNA antibody assay: high specificity and sensitivity with a filtration radioassay in comparison to low specificity with standard ELISA. J Rheumatol, 34 (4), 734-739. , PMID: 17407230

Zhang L, Barker JM, Babu S, Su M, Stenerson M, Cheng M, Shum A, Zamir E, Badolato R, Law A, Eisenbarth GS, Anderson MS (2007). A robust immunoassay for anti-interferon autoantibodies that is highly specific for patients with autoimmune polyglandular syndrome type 1. Clin Immunol, 125 (2), 131-137. , PMID: 17825626, PMCID: PMC2080870

Kis J, Engelmann P, Farkas K, Richman G, Eck S, Lolley J, Jalahej H, Borowiec M, Kent SC, Treszl A, Orban T. (2007). Reduced CD4+ subset and Th1 bias of the human iNKT cells in Type 1 diabetes mellitus. J Leukoc Biol, 81 (3), 654-662. , PMID: 17151140

Aly TA, Eller E, Ide A, Gowan K, Babu SR, Erlich HA, Rewers MJ, Eisenbarth GS, Fain PR (2006). Multi-SNP analysis of MHC region: Remarkable conservation of HLA-A1-B8-DR3 haplotype. Diabetes, 55 (5), 1265-1269. , PMID: 16644681

Aly TA, Ide A, Jahromi MM, Barker JM, Fernando MS, Babu SR, Yu L, Miao D, Erlich HA, Fain PR, Barriga KJ, Norris JM, Rewers MJ, Eisenbarth GS (2006). Extreme genetic risk for type 1A diabetes. Proc Natl Acad Sci, 103 (38), 14074-14079. , PMID: 16966600, PMCID: PMC1563993

Casale TB, Busse WW, Kline JN, Ballas ZK, Moss MH, Townley RG, Mokhtarani M, Seyfert-Margolis V, Asare A, Bateman K, Deniz Y, Immune Tolerance Network (2006). Omalizumab pretreatment decreases acute reactions following rush immunotherapy for ragweed-induced seasonal allergic rhinitis. J Allergy Clin Immunol, 117 (1), 134-140. , PMID: 16387596

Creticos PS, Schroeder JT, Hamilton RG, Balcer-Whaley SL, Khattignavong AP, Lindblad R, Li H, Coffman R, Seyfert V, Eiden JJ, Broide D, Immune Tolerance Network Group (2006). Immunotherapy with a ragweed–toll-like receptor 9 agonist vaccine for allergic rhinitis. New Engl J Med, 355 (14), 1445-1455. , PMID: 17021320

Fudaba Y, Spitzer TR, Shaffer J, Kawai T, Fehr T, Delmonico F, Preffer F, Tolkoff-Rubin N, Dey BR, Saidman Sl, Kraus A, Bonnefoix T, McAfee S, Power K, Kattleman K, Colvin RB, Sachs DH, Cosimi AB, Sykes M (2006). Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses. Am J Transplant, 6 (9), 2121-2133. , PMID: 16796719

Seyfert-Margolis V, Gisler TD, Asare AL, Wang RS, Dosch HM, Brooks-Worrell B, Eisenbarth GS, Palmer JP, Greenbaum CJ, Gitelman SE, Nepom GT, Bluestone JA, Herold KC (2006). Analysis of T cell assays to measure autoimmune responses in subjects with type 1 diabetes: results of a blinded controlled study. Diabetes, 55 (9), 2588-2594. , PMID: 16936208

Shamji MH, Wilcock LK, Wachholz PA, Dearman RJ, Kimber I, Wurtzen PA, Larché M, Durham SR, Francis JN (2006). The IgE-facilitated allergen binding (FAB) assay: validation of a novel flow-cytometric based method for the detection of inhibitory antibody responses. J Immunol Meth, 317 (1-2), 71-79. , PMID: 17070537, PMCID: PMC1934503

Shapiro AM, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, Robertson RP, Secchi A, Brendel MD, Berney T, Brennan DC, Cagliero E, Alejandro R, Ryan EA, DiMercurio B, Morel P, Polonsky KS, Reems JA, Bretzel RG, Bertuzzi F, Froud T, Kandaswamy R, Sutherland DE, Eisenbarth G, Segal M, Preiksaitis J, Korbutt GS, Barton FB, Viviano L, Seyfert-Margolis V, Bluestone J, Lakey JR (2006). International trial of the Edmonton protocol for islet transplantation. New Engl J Med, 355 (13), 1318-1330. , PMID: 17005949

Bourdette DN, Edmonds E, Smith C, Bowen JD, Guttmann CR, Nagy ZP, Simon J, Whitham R, Lovera J, Yadav V, Mass M, Spencer L, Culbertson N, Bartholomew RM, Theofan G, Milano J, Offner H, Vandenbark AA (2005). A highly immunogenic trivalent T cell receptor peptide vaccine. Multiple Sclerosis, 11 (5), 552-561. , PMID: 16193893

Bunde T, Kirchner A, Hoffmeister B, Habedank D, Hetzer R, Cherepnev G, Proesch S, Reinke P, Volk HD, Lehmkuhl H, Kern F (2005). Protection from cytomegalovirus after transplantation is correlated with immediate early 1–specific CD8 T cells. J Exp Med, 201 (7), 1031-1036. , PMID: 15795239, PMCID: PMC2213133

Danke NA, Koelle DM, Kwok WW (2005). Persistence of herpes simplex virus type 2 VP16-specific CD4(+) T cells. Hum Immunol, 66 (7), 777-787. , PMID: 16112025

Game DS, Hernandez-Fuentes MP, Lechler RI (2005). Everolimus and basiliximab permit suppression by human CD4+CD25+ cells in vitro. Am J Transplant, 5 (3), 454-464. , PMID: 15707399

Giannoni F, Barnett J, Bi K, Samodal R, Lanza P, Marchese P, Billetta R, Vita R, Klein MR, Prakken B, Kwok WW, Sercarz E, Altman A, Albani S (2005). Clustering of T cell ligands on artificial APC membranes influences T cell activation and protein kinase C theta translocation to the T cell plasma membrane. J Immunol, 174 (6), 3204-3211. , PMID: 15749850

Gonzalez JC, Kwok WW, Wald A, McClurkan CL, Huang J, Koelle DM (2005). Expression of cutaneous lymphocyte-associated antigen and E-selectin ligand by circulating human memory CD4+ T lymphocytes specific for herpes simplex virus type 2. J Infect Dis, 191 (2), 243-254. , PMID: 15609235, PMCID: PMC1255909

Huan J, Culbertson N, Spencer L, Bartholomew R, Burrows GG, Chou YK, Bourdette D, Ziegler SF, Offner H, Vandenbark AA (2005). Decreased Foxp3 levels in multiple sclerosis patients. J Neurosci Res, 81 (1), 45-52. , PMID: 15952173

Mallone R, Kochik SA, Reijonen H, Carson B, Ziegler SF, Kwok WW, Nepom GT (2005). Functional avidity directs T-cell fate in autoreactive CD4+ T-cells. Blood, 106 (8), 2798-2805. , PMID: 16030184, PMCID: PMC1895305

Muthukumar T, Dadhania D, Ding R, Snopkowski C, Nagvi R, Lee JB, Hartono C, Li B, Sharma VK, Seshan SV, Kapur S, Hancock WW, Schwartz JE, Suthanthiran M (2005). Messenger RNA for FOXP3 in the urine of renal allograft recipients. New Engl J Med, 353 (22), 2342-2351. , PMID: 16319383

Offner H, Vandenbark AA (2005). Congruent effects of estrogen and T cell receptor peptide therapy on regulatory T cells in EAE and MS. Intl Rev Immunol, 24 (5-6), 447-477. , PMID: 16318990

Vandenbark AA (2005). TCR peptide vaccination in multiple sclerosis: boosting a deficient natural regulatory network that may involve TCR-specific CD4. Curr Drug Targets Inflamm Allergy, 4 (2), 217-229. , PMID: 15853744

Barker JM, Barriga KJ, Yu L, Miao D, Erlich HA, Norris JM, Eisenbarth GS, Rewers M, Diabetes Autoimmunity Study in the Young (2004). Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). J Clin Endocrinol Metab, 89 (8), 3896-3902. , PMID: 15292324

Barker JM, Goehrig SH, Barriga K, Hoffman M, Slover R, Eisenbarth GS, Norris JM, Klingensmith GJ, Rewers M, DAISY Study (2004). Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up. Diabetes Care, 27 (6), 1399-1404. , PMID: 15161795

Brennan DC, Shannon MB, Koch MJ, Polonsky KS, Desai N, Shapiro J (2004). Portal vein thrombosis complicating islet transplantation in a recipient with the Factor V Leiden mutation. Transplantation, 78 (1), 172-173. , PMID: 15257060

Danke NA, Koelle DM, Yee C, Beheray S, Kwok WW (2004). Autoreactive T cells in healthy individuals. J Immunol, 172 (10), 5967-5972. , PMID: 15128778

Mallone R, Kochik SA, Laughlin EM, Gersuk VH, Reijonen H, Kwok WW, Nepom GT (2004). Differential recognition and activation thresholds in human autoreactive GAD-specific T-cells. Diabetes, 53 (4), 971-977. , PMID: 15047612

Maus MV, Kovacs B, Kwok WW, Nepom GT, Schlienger K, Riley JL, Allman D, Finkel TH, June CH (2004). Extensive replicative capacity of human central memory T cells. J Immunol, 172 (11), 6675-6683. , PMID: 15153483

Yang J, Jaramillo A, Shi R, Kwok WW, Mohanakumar T (2004). In vivo biotinylation of the major histo-compatibility complex (MHC) class II/peptide complex by co-expression of BirA enzyme for the generation of MHC class II/tetramers. Hum Immunol, 65 (7), 692-699. , PMID: 15301857

Ding R, Li B, Muthukumar T, Dadhania D, Medeiros M, Hartono C, Serur D, Seshan SV, Sharma VK, Kapur S, Suthanthiran M (2003). CD103 mRNA levels in urinary cells predict acute rejection of renal allografts. Transplantation, 5 (8), 1307-1312. , PMID: 12717221

Mazariegos GV, Zahorchak AF, Reyes J, Ostrowski L, Flynn B, Zeevi A, Thomson AW (2003). Dendritic cell subset ratio in peripheral blood correlates with successful withdrawal of immunosuppression in liver transplant patients. Am J Transplant, 3 (6), 689-696. , PMID: 12780560

Muthukumar T, Ding R, Dadhania D, Medeiros M, Li B, Sharma VK, Hartono C, Serur D, Seshan SV, Volk HD, Reinke P, Kapur S, Suthanthiran M (2003). Serine proteinase inhibitor-9, an endogenous blocker of granzyme B/perforin lytic pathway, is hyperexpressed during acute rejection of renal allografts. Transplantation, 75 (9), 1565-1570. , PMID: 12792516

Reijonen H, Kwok WW (2003). Use of HLA class II tetramers in tracking antigen-specific T cells and mapping T-cell epitopes. Methods, 29 (3), 282-288. , PMID: 12725793

Miao D, Yu L, Tiberti C, Cuthbertson DD, Rewers M, di Mario U, Eisenbarth GS, Dotta F (2002). ICA512(IA-2) Epitope specific assays distinguish transient from diabetes associated autoantibodies. J Autoimmun, 18 (2), 191-196. , PMID: 11908951

Gebauer BS, Hricik DE, Atallah A, Bryan K, Riley J, Tary-Lehmann M, Greenspan NS, Dejelo C, Boehm BO, Hering BJ, Heeger PS (2002). Evolution of the Enzyme-Linked Immunosorbent Spot Assay for post-transplant alloreactivity as a potentially useful immune monitoring tool. Am J Transplant, 2 (9), 857-866. , PMID: 12392292

Ding R, Medeiros M, Dadhania D, Muthukumar T, Kracker D, Kong JM, Epstein SR, Sharma VK, Seshan SV, Li B, Suthanthiran M (2002). Noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK virus VP1 in urine. Transplantation, 74 (7), 987-994. , PMID: 12394843

Thomson AW, Mazariegos GV, Reyes J, Donnenberg VS, Donnenberg AD, Bentlejewski C, Zahorchak AF, O'Connell PJ, Fung JJ, Jankowska-Gan E, Burlingham WJ, Heeger PS, Zeevi A (2001). Monitoring the patient off immunosuppression: Conceptual framework for a proposed tolerance assay study in liver transplant recipients. Transplantation, 72 (8), S13-S22. , PMID: 11888150

Bluestone JA, Matthews JB, Krensky AM (2000). The Immune Tolerance Network: The "Holy Grail" comes to the clinic. J Am Soc Nephrol, 11 (11), 2141-2146. , PMID: 11053493

Abstract

Burlingham WJ, Jankowska-Gan E, Gawin D, Haynes L, Knechtle S, Djamali A (2010). 4 Yr Follow-Up of an ITN-Sponsored, Alemtuzimab-Based Tolerance Induction Trial: Donor-Specific Regulation [DSR] Identifies Renal Transplants with Superior Outcome. (Abstract #1563) 2010 American Transplant Congress, San Diego, CA, May 1-5, 2010.

Casale TB, Scheuermann RH, Qian Y, Kong M, Campbell J, Sadat E, Thomson E, Dunn P, Xiang D, Dahlke CE (2010). Automated analysis of flow cytometry data for the identification of cellular markers of allergy therapeutic responses. (Abstract #(J. Immunol., Apr 2010; 184: 91.2)) Immunology 2010 (97th Annual Meeting of the American Association of Immunologists), Baltimore, MD, May 13-17, 2010.

Bourcier K, Seyfert-Margolis V, Grant J, Liu Z, Wallace S, Wallace P (2010). Bourcier ISAC 2010.05. XXV Congress of the International Society for the Advancement of Cytometry, Seattle, WA, May 8-12, 2010.

Lim N, Kanaparthi S, Mertens S, Gopalakrishnan N, Gao Z, Liu Z, Bourcier K, Phippard D, Asare A (2010). Quality assessments of un-gated flow cytometry FCS files in a clinical trial setting. XXV Congress of the International Society for the Advancement of Cytometry, Seattle, WA, May 8-12, 2010.

Ekong U, Tchao NK, Feng S, Demetris AJ, Ruppert K, Lobritto SJ (2010). Prospective evaluation of histopathology biopsy features that predict successful weaning and comparison to protocol follow-up bi. American Association for the Study of Liver Diseases (AASLD), Boston, MA, October 29-November 2, 2010, 2010.

Kanaparthi S, Lim N, Mertens S, Gopalakrishnan N, Liu Z, Phippard D, Asare A, Bouricer K (2010). A high throughput approach to quality assessment of un-gated, clinical flow cytometric immunophenotyping data. (Abstract #S.31) Federation of Clinical Immunology Societies (FOCIS), Boston, MA, June 24-27, 2010, 2010.

Asare A, Lim N, Bourcier K, Phippard D, Philogene MC, Ali H, Asare S (2010). Banking RNA for biomarker discovery: Assessing RNA quality and yield for long term use. (Abstract #S.63) Federation of Clinical Immunological Societies (FOCIS), Boston, MA, June 24-27, 2010, 2010.

Feng S, Ekong U, Lobritto S, Demetris A, Rosenthal P, Alonso E, Tchao N (2009). ITN029ST: Immunosuppression Withdrawal in Pediatric Recipients of Parental Living Donor Liver Transplants: Preliminary Results of a Pilot Study. (Abstract #189) American Transplant Congress, Boston, MA, May 30 - Jun 3, 2009.

Newell KA, Asare A, Kirk AD, Suthanthiran M, Burlingham WJ, Bourcier K, Marks WH, Turka LA, Seyfert-Margolis V, Gisler T (2009). Peripheral B Cell Markers Identify Tolerant Renal Transplant Recipients. (Abstract #LB08) American Transplant Congress, Boston, MA, May 30 - Jun 3, 2009.

Perucha E, Sagoo P, Sawitzki B, Tomiuk S, Stephens DA, Miqueu P, Chapman S, Craciun L, Brouard S, Giral M, Seyfert-Margolis V, Wood K, Lechler RI, Hernandez-Fuentes M, Newell K, Turka L, Goldman M, Warrens A, Volk HD, Soulillou JP, Janssen U, www.transplant-tolerance.org.uk/ParticipantPhysicians.aspx (2009). Lechler 2009 ATC Abstract. (Abstract #1561) American Transplant Congress, Boston, MA, May 30 - Jun 3, 2009.

Porcheray F, Wong W, Saidman Sl, Girouard TC, Chittenden M, Shaffer J, Tolkoff-Rubin N, Dey BR, Spitzer TR, Colvin RB, Cosimi AB, Kawai T, Sachs DH, Sykes M, Zorn E, DeVito J (2009). B-cell immunity in the context of T-cell tolerance after combined kidney and bone marrow transplantation in humans. (Abstract #307) American Transplant Congress, Boston, MA, May 31-Jun 4, 2009.

Herold, KA (2009). New Modalities of Immunoassessment – The Immune Tolerance Network Experienc. FOCIS 2009, San Francisco, CA, June 11-14, 2009.

Raddassi K, Yang J, Bourcier K, Seyfert-Margolis V, Hafler DA, Kent S, Bradshaw E, Kwok W (2009). Detection of Myelin Reactive CD4+ Cells in the Peripheral Blood of Patients with Multiple Sclerosis using MhC Class II Tetramers. (Abstract #S67) FOCIS 2009, San Francisco, CA, June 11-14, 2009.

Andreola G, Chittenden M, Shaffer J, Cosimi AB, Kawai T, Dey BR, Tolkoff-Rubin N, Preffer F, Saidman S, Kattleman K, Spitzer TR, Sachs DH, Sykes M, Cotter P (2009). Mechanisms of Donor-speci\c Unresponsiveness Following Loss of Chimerism in Recipients of haploidentical Combined Bone Marrow/Kidney Transplantation. (Abstract #T32) FOCIS 2009, San Francisco, CA, June 11-14, 2009.

Hernandez-Fuentes (2009). Hernandez-Fuentes - Madrid 2009. III Jornada de Inmunospresion Clinica y Experimental en Transplantes (ICET), Madrid, Spain, 22 January, 2009.

Stone JH, Specks U, ITN RAVE (ITN021AI) Study Group (2009). Rituximab for ANCA-associated Vasculitis (RAVE) Trial. 14th Int'l Vasculitis and ANCA Workshop, Lund, Sweden, 6-9 June, 2009.

Bowen JD, Sayre P, Stüve O, Wundes A, Kraft GH, Hutton GJ, Openshaw H, Forman SJ, Frohman EM, Griffith LM, Muraro PA, Racke MK, Popat U, Nash RA (2009). HALT MS - Phase II Clinical Trial of High Dose Immunosuppressive Therapy and Autologous Hematopoietic Stem Cell Transplantation for Active Relapsing-Remitting Multiple Sclerosis. 2009 Annual Meeting of the American Academy of Neurology, Tuczon, AZ, 25-27 June, 2009.

Hutton GJ, Bowen JD, Forman SJ, Frohman EM, Griffith LM, Kraft GH, Openshaw H, Popat U, Racke M, Sayre P, Stüve O, Wundes A, Nash RA, Muraro P (2009). HALT-MS—Intense Immunosuppression and Stem Cell Transplantation for RRMS. 23rd Annual Meeting of the Consortium of MS Centers, Atlanta, GA, 27-30 May, 2009.

Shamji MH, James LK, Francis JN, Kimber I, Till SJ, Durham SR (2009). Shamji - EAACI 2009. XXVIII Congress of the European Academy of Allergy, Asthma and Immunology (EAACI), Warsaw, Poland, 6-10 June, 2009.

Emmanuelle Waubant, Daniel Pelletier, Michele Mass, Jeff Cohen, Mariko Kita, Anne Cross, Amit Bar-Or, Timothy Vollmer, Michael Racke, Olaf Stuve, Steven Schwid, Andrew Goodman, Norman Kachuck, Jana Preiningerova, Bianca Weinstock-Guttman, Peter Calabresi, Aaron Miller, Masoud Mokhtarani, David Iklé, Linna Ding, Ellen Rosenberg, ITN020AI Study Management Team, Collin Spencer, Scott S. Zamvil (2009). Atorvastatin therapy in patients with Clinically Isolated Syndrome (CIS) and High Risk for Conversion to Multiple Sclerosis (MS): the STAyCIS study. ECTRIMS, Dusseldorf, Germany, September 9-12, 2009.

Waubant E, Pelletier D, Mass M, Cohen J, Kita M, Cross A, Bar-Or A, Vollmer T, Racke M, Stüve O, Schwid S, Goodman A, Kachuck N, Preiningerova J, Weinstock-Guttman B, Calabresi P, Miller A, Mokhtarani M, Ikle D, Ding L, Rosenberg E, ITN020AI Study Management Team, Spencer C, Zamvil SS (2009). Atorvastatin therapy in patients with Clinically Isolated Syndrome (CIS): the STAyCIS study. 134th Annual Meeting, American Neurological Assocation, Baltimore, MD, October 11-14, 2009, 2009.

Spitzer TR, Sykes M, Tolkoff-Rubin N, Kawai T, Dey BR, Delmonico F, Saidman S, Cosimi AB, McAfee SL, Ballen K, Sachs DA (2009). Long Term Follow-up of Recipients of Combined HLA-Matched Nonmyeloablative Bone Marrow and Kidney Transplantation for Multiple Myeloma with End-Stage Renal Disease. American Sociey of Hematology, New Orleans, LA, December 5-8. 2009, 2009.

Collins AB, Colvin RB, Cornell LD, Della Pelle P, Brousiadies N (2008). Endothelial response to rejection: Enhanced expression of complement regulatory proteins decay accelerating factor (DAF,. Mod Pathol, 17, 285A, 2008.

Hamilton RG, Bourcier K, Lack G, Durham SR, Seyfert-Margolis V, Hovanec-Burns D, Francis GN, Aalberse RC (2008). Allergen-Specific IgG and IgG4 Autoanalyzer Performance and Utility in Assessing Immunotherapy Study Specimens. Annual Meeting of the AAAAI, Philadelphia, PA, March 14-18, 2008.

Kraft GH, Bowen JD, Openshaw H, Forman SJ, Frohman EM, Griffith LM, Hutton GJ, Muraro PA, Popat U, Racke MK, Sayre P, Stüve O, Wundes A, Nash RA (2008). Phase II Clinical Trial (HALT MS: Immune Tolerance Network) Of High Dose Immunosuppressive Therapy (HDIT) and Autologous H. American Academy of Neurology, Chicago, IL, April 12-19, 2008.

Newell KA, Asare A, Gisler T, Turka L, Seyfert-Margolis V, Suthanthiran MS, Burlingham W, Marks W (2008). A Unique B cell Signature Associated with Operational Tolerance. American Transplant Congress, Toronto, Canada, May 31-Jun 4, 2008.

Hernandez-Fuentes M, Perucha E, Sagoo P, Hilton R, Sergeant R, Waters J, Roberts I, Warrens AN, Lechler R, Ballow AA, Wood KJ (2008). Post-transplant detection of anti-HLA antibodies: risk factors and clinical relevance. British Renal Association, Glasgow, Scotland, May, 2008.

Hernandez-Fuentes M, Sawitzki B, Perucha E, Sagoo P, Miqueu P, Chapman S, Stephens D, Craciun L, Hilton R, Sergeant R, Tomiuk S, Janssen U, Goldman M, Soulillou JP, Warrens A, Wood K, Volk HD, Lechler R, Roberts I, http://www.transplant-tolerance.org.uk/Participant%20 Physicians.aspx (2008). Immunetolerance fingerprint in renal transplants. British Transplantation Society, Glasgow, Scotland, April, 2008.

Hernandez-Fuentes MP, Sawitzki B, Perucha E, Sagoo P, Miqueu P, Chapman S, Craciun L, Tomiuk S, Brouard S, Giral M, Janssen U, Goldman M, Wood K, Warrens A, Volk HD, Soulillou JP, Lechler RI, Stephens D (2008). Identification of Immune Tolerance in renal transplants. American Transplant Congress, Toronto, Canada, May 31-Jun 4, 2008.

Perucha E, Hernandez-Fuentes M, Sagoo P, Hilton R, Sergeant R, Warrens AN, Waters J, Lechler R (2008). Differential effect on CNI treatment in T cell activation on T lymphocytes from renal transplant recipients. British Renal Association, Glasgow, Scotland, May, 2008.

Bourcier K, Turka LA, Sayegh MH, Vadivel N, Lopez M, Hill R, Najafian N (2008). A Novel Immune Monitoring Assay in Transplant Recipients. (Abstract #783) American Transplant Congress, Toronto, Canada, May 31-Jun 4, 2008.

Knechtle S, Pascual J, Jankowska-Gan E, Bourcier K, Seyfert-Margolis V, Burlingham W, Bloom D, Torrealba J, Harper L, Colvin R, Sollinger H (2008). Sirolimus Monotherapy in Kidney Transplantation: Results of an ITN-Sponsored Trial. (Abstract #134) American Transplant Congress, Toronto, Canada, May 31-Jun 4, 2008.

Asare A, Gao Z, Wang R, Seyfert-Margolis V, Carey V (2008). Gene expression quality assurance algorithm improves statistical power in clinical immune tolerance studies. Immunology and Gene Expression, Cold Spring Harbour, NY, April 22-26, 2008.

Hernandez-Fuentes M, Sagoo P, Perucha E, Sawitzki B, Miqueu P, Craciun L, Sergeant R, Ballow A, Chapman S, Tomiuk S, Roberts I, Stephens D, Janssen U, Wood K, Warrens A, Goldman M, Soulillou JP, Volk HD, Lechler RI (2008). Hernandez-Fuentes - AST Fellows 2009. AST Distinguished Fellows Research Forum, San Diego, CA, April, 2008.

Demetris AJ, Ruppert K, Ekong U, Rosenthal P, Sayre P, Tchao N, Feng S (2007). Morphometric and Histopathologic Analysis of Protocol Biopsies from Stable, Long-Surviving Pediatric Recipients of Livi. (Abstract #909) American Transplant Congress, San Francisco, CA, May 5-9, 2007.

Francis JN, Saggar LR, Seyfert-Margolis V, Asare AL, Klunker S, Casale TB, Durham SR, Immune Tolerance Network Group (2007). The combination of anti-IgE monoclonal antibody (omalizumab) with ragweed immunotherapy results in enhanced and long-ter. XXVI Meeting of the EAACI, Goteborg, Sweden, June 9-13, 2007.

ITN Tolerance Assay and Data Analysis Group, ITN Clinical Trials Group, ITN TILT Study Investigators (2007). Kinetics of Immune Cell Depletion and Reconstitution with Alemtuzumab: A Possible Explanation for Low Incidence of Oppor. (Abstract #1735) American Transplant Congress, San Francisco, CA, May 5-9, 2007.

Kawai T, Sachs DH, Spitzer T, Tolkoff-Rubin N, Saidman S, Williams W, Dey B, Ko D, Wong W, Colvin RB, Sykes M, Cosimi AB, Goes N (2007). The Long-Term Evaluation of HLA-Mismatched Combined Kidney and Bone Marrow Transplant Recipients after Complete Withdrawal. (Abstract #1717) American Transplant Congress, San Francisco, CA, May 5-9, 2007.

Kawai T, Suthanthiran M, Sharma V, Ding R, Sykes M, Colvin RB, Cosimi AB, Sachs DH (2007). Intragraft RNA Expression of FOXP3 Versus Proinflammatory Cytokines in Tolerant Recipients of HLA Mismatched Renal Allogra. (Abstract #2) American Transplant Congress, San Francisco, CA, May 5-9, 2007.

Knechtle S, Sollinger H, Bloom D, Hu H, Janus C, Radke N, Davis Z (2007). A Tolerance Trial in Kidney Transplantation Based on T-cell Depletion, Tacrolimus, and Sirolimus . American Transplant Congress, San, May 5-9, 2007.

Nash RA, Openshaw H, Bowen JD, Forman SJ, Stüve O, Popat U, Hutton G, Kraft G (2007). A Phase II Study of High-Dose Immunosuppressive Therapy (HDIT) Using Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM. 22nd Annual Meeting of the CMSC, Denver, CO, May 28-31, 2007.

Asare AL, Bourcier K, Wang R, Gao Z, Casale TB, Seyfert VL (2007). Transcriptome Seasonal Regulation in Ragweed Allergy. 2007 AAAAI Annual Meeting, San Diego, CA, Feb 23-27, 2007.

Hernandez-Fuentes M, Sagoo P, Sawitzki B, Perucha E, Jimenez-Vera E, Craciun L, Brouard S, Chapman S, Janssen U, Warrens AN, Goldman M, Volk HD, Soulillou JP, Wood K, Lechler RI (2007). Tregs in peripheral blood of clinically defined groups of renal transplant recipients. British Society of Immunology, Unknown, February, 2007.

Hernandez-Fuentes MP, Sawitzki B, Sagoo P, Craciun L, Brouard S, Perucha E, Chapman S, Roberts I, Sergeant R, Janssen U, Warrens AN, Wood K, Soulillou JP, Goldman M, Volk HD, Lechler RI, Bradeau C, Peters B, www.transplant-tolerance.org.uk/team.aspx, www.transplant-tolerance.org.uk/physicians/ (2007). Biomarkers of tolerance in kidney transplants. American Transplant Congress, San Francisco, CA, May 5-9, 2007.

Hernandez-Fuentes MP, Sawitzki B, Sagoo P, Perucha E, Craciun L, Giral M, Chapman S, Peters B, Waters J, Roberts I, Sergeant R, Soulillou JP, Wood K, Warrens A, Janssen U, Goldman M, Volk HD, Lechler RI.Participants www.transplant-tolerance.org.uk/team.aspx and Collaborators www.transplant-tolerance.org.uk/physicians/ (2007). Indices of tolerance in kidney . The Renal Association Annual Conference, Brighton, UK, May, 2007.

Sagoo P, Sawitzki B, Hernandez-Fuentes MP, Perucha E, Craciun L, Brouard S, Chapman S, Bradeau C, Peters B, Roberts I, Janssen U, Soulillou JP, Warrens AN, Wood K, Goldman M, Volk HD, Lechler RI, www.transplant-tolerance.org.uk/team.aspx, www.transplant-tolerance.org.uk/physicians/ (2007). Monitoring peripheral blood regulatory T cells on clinically defined groups of kidney transplant recipients. American Transplant Congress, San Francisco, CA, May 5-9, 2007.

Sawitzki B, Hernandez-Fuentes MP, Sagoo P, Perucha E, Brouard S, Chapman S, Peters B, Roberts I, Janssen U, Soulillou JP, Warrens AN, Wood K, Goldman M, Lechler RI, Volk HD, Lemoine A (2007). Identification of tolerant patients based on a combinatorial analysis of Foxp3 and aMannosidase transcription. American Transplant Congress, San Francisco, CA, May 5-9, 2007.

Tchao N, Sayre P, Feng S, Klintmalm G, Punch J, Ikle D, Shaked A, Fung J, Trotter C (2007). Long-term immunosuppression management in OLT recipients. American Transplant Congress, San Francisco, CA, May 5-9, 2007.

Hernandez-Fuentes M, Sagoo P, Perucha E, Sawitzki B, Miqueu P, Craciun L, Sergeant R, Ballow A, Chapman S, Tomiuk S, Roberts I, Stephens D, Janssen U, Wood K, Warrens A, Goldman M, Soulillou JP, Volk HD, Lechler RI (2007). Tools to detect immunological tolerance in renal transplants . AST Distinguished Fellows Research Forum, San Diego, CA, Unknown, 2007.

Raddassi K, Bourcier K, Estevam J, Seyfert-Margolis V, Hafler D (2007). Improving elispot to detect antigen specific T cells. FOCIS, San Diego, CA, June 7-11, 2007.

Raddassi K, Bourcier K, Seyfert-Margolis V, Estevam J, Hafler D (2007). Elifacs a multiplex assay to detect antigen specific T cells and to monitor the immune response. FOCIS, San Diego, CA, June 7-11, 2007.

Srikantha M, Sergeant R, Hernandez-Fuentes M, Lechler RI, Warrens AN (2007). Is it possible to tissue type a kidney donor who is no longer available?. (Abstract #463) American Transplant Congress, San Francisco, CA, May 5-9, 2007.

O'Connor MJ, Shankar RD, Parrish D, Das AK (2007). Knowledge-level Querying of Temporal Patterns in Clinical Research Systems. 12th World Congress on Health (Medical) Informatics, Brisbane, Australia, Aug 20-24, 2007.

Shankar RD, Martins SB, O'Connor MJ, Parrish DB, Das AK (2007). An Ontology-based Architecture for Integration of Clinical Trials Management Applications. AMIA Annual Symposium, Chicago, IL, Nov 9-15, 2007.

O'Connor MJ, Shankar RD, Parrish DB, Das AK, Tu SW, Nyulas CI, Musen MA (2007). Using Semantic Web Technologies for Knowledge-Driven Querying of Biomedical Data. 11th Conference on Artificial Intelligence in Medicine (AIME2007), Amsterdam, Netherlands, July 7-11, 2007.

Hernandez-Fuentes MP, Sagoo P, Jimenez-Vera E, Rovis F, Waters J, Hilton R, Warrens AN, Lechler R (2006). Indices of immunological tolerance in renal transplantation: Interim analysis. (Abstract #123) 9th Congress of the British Transplantation Society, Seattle, Washington, March 29-31, 2006.

Newell KA, Burlingham WJ, Marks WH, Gisler TD, Seyfert VL, Turka LA, Suthanthiran M, Kirk AD (2006). Preliminary Analysis of the ITN Registry of Tolerant Kidney Transplant Recipients. World Transplant Congress, Boston, MA, July 22 – 27, 2006.

Carreno M, Ciancio G, Burke GW, Cirocco R, Mathew J, Miller J, Esquenazi V, Gomez C, Salma F, Jin Y (2006). Precursor dendritic cell subsets in kidney allograft recipients after induction with alemtuzumab (C1H) vs thym. ASHI 31st Annual Meeting, San Diego, CA, October 17, 2006.

Boyce K, Spencer T (2006). Using automated extract, transform and load (ETL) processes to build an integrated warehouse of clinical and mechanistic results. American Medical Informatics Association Symposium Spring Congress, Phoenix, AZ, May, 2006.

Cirocco R, Carreno M, Mathew J, Vallone T, Rosen A, Burke GW, Ciancio G, Esquenazi V, Miller J, Kleiner G (2006). Upregulation of FOXP3 in renal transplantation after antibody induction regimens with and without bone marrow or stem cells. World Transplant Congress, Boston, MA, July 22-27, 2006.

Francis JN, Wilcock LK, Paraskavopoulos G, Till SJ, Durham SR (2006). Time-course analysis of a Double-Blind Placebo Controlled Trail of Grass Pollen Immunotherapy: increased cellular IL-10 . Collegium Internationale Allergologicum, Malta, May 5-10, 2006.

Hernandez-Fuentes MP, Sagoo P, Flavia R, Jimenez E, Perucha E, Le Moine A, Craciun L, Peters B, Braudeau C, Brouard S, Chapman S, Warrens A, Goldman M, Soulillou JP, Janssen U, Wood K, Lechler RI, Sawitszki B, Trzonkowski P, Warnecke G, Libin M, Volk H-D (2006). Indices of tolerance: Interim Report. (Abstract #999) World Transplant Congress, Boston, MA, July 22-27, 2006.

Kawai T, Spitzer T, Tolkoff-Rubin N, Saidman S, Dey B, Goes N, Ko D, Hertl M, Cotter P, Wong W, Colvin R, Sykes M, Cosimi AB, Sachs D, WilliamsW (2006). Successful Induction of Renal Allograft Tolerance in HLA-Mismatched Kidney Transplant Recipients. FASEB Summer Research Conference, Snowmass, CO, June 3-8, 2006.

Klunker S, Francis JN, Casale TB, Durham SR (2006). Anti-IgE Therapy Inhibits IgE-facilitated Allergen Presentation and Increases the Efficacy of Ragweed Immunotherapy. 2006 AAAAI Annual Meeting, Miami, FL, March 3-7, 2006.

Knechtle SJ, Sollinger HW, Jankowska-Gan E, Burlingham WJ, Bloom DJ (2006). Preliminary results of a tolerance trial in renal transplantation. World Transplant Congress, Boston, MA, July 22-27, 2006.

Mathew J, Carreno M, Cirocco R, Rosen A, Vallone T, Garcia-Morales R, Burke GW, Ciancio G, Esquenazi V, Miller J (2006). Circulating and graft infiltrating regulatory cells in donor stem cell infused kidney transplant patients treated with alemtuzumab. 12th Innovative Therapeutics in Transplantation Meeting, Nantes, France, June 15, 2006.

Mathew J, Cirocco R, Rosen A, Vallone T, Gomez C, Blomberg B, Fuller L, Burke GW, Ciancio G, Esquenazi V, Miller J (2006). Tolerogenicity of graft infiltrating lymphocytes in donor stem cell infused kidney transplant recipients treated with ale. ASHI 31st Annual Meeting, San Diego, CA, October 17, 2006.

Mathew J, Vallone T, Carreno M, Garcia-Morales R, Rosen A, Gomez C, Burke GW, Ciancio G, Esquenazi V, Miller J, Blomberg B, Fuller L (2006). Regulatory cells of donor and recipient phenotypes in donor stem cell infused kidney transplant recipients treated with a. World Transplant Congress, Boston, MA, July 22-27, 2006.

Parrish D, McCafferty K (2006). A web-based clinical trials management system: Integration, annotation and delivery of bioinformatics and clinical data w. American Medical Informatics Association Spring Congress, Phoenix, AZ, May, 2006.

Raddassi K, Bourcier K, Estevam J, Gisler T, Hafler DA, Seyfert-Margolis V (2006). Comparison of two methods CPT and Ficoll to isolate mononuclear cells from peripheral blood. Effect on viability and fu. FOCIS Annual Meeting, San Francisco, CA, June 1-5, 2006.

Sagoo P, Hernandez-Fuentes M, Jimenez-Vera E, Rovis F, Hilton R, Warrens A, Lechler RI (2006). Fingerprinting tolerance in Renal Transplantation. (Abstract #A21) 7th Trends in Immunosuppression, Berlin, Germany, February, 2006.

Sagoo P, Hernandez-Fuentes MP, Jimenez E, Perucha E, Warrens A, Lechler RI, Flavia R, Stevenson S, Milton R (2006). Advances in Immune Monitoring in Renal Transplantation. (Abstract #1888) World Transplant Congress, Boston, MA, July 22-27, 2006.

Shamji MH, Wilcock LK, Larché M, Francis JN, Durham SR (2006). Validation of a Functional Assay of IgE-Facilitated CD23-Dependent Allergen Binding to B Cells to Monitor Clinical Effica. 2006 AAAAI Annual Meeting, Miami, FL, March 3-7, 2006.

Stevenson S, Hernandez-Fuentes M, Lechler RI, Jiang S, Lombardi G, Barber L (2006). Efficacy of Indirect pathway antigen processing and allorecognition. (Abstract #918) 7th Trends in Immunosuppression, Berlin, Germany, February, 2006.

Vandenbark AA (2006). Treatment of MS patients with TCR peptide vaccine. 4th International Workshop on T-Cell Vaccination, Galillee, Israel, February, 2006.

Wilcock LK, Francis JN, Till SJ, Durham SR, Paraskavopoulos G (2006). Induction of IL-10 Occurs Early and Precedes Serum IgG Blocking Activity During a Cluster Regimen of Grass Pollen Immuno. 2006 AAAAI Annual Meeting, Miami, FL, March 3-7, 2006.

Wilcock LK, Francis JN, Aalberse RC, Till SJ, Durham SR, Paraskevopolous G, Stapel SO (2006). Increased serum inhibitory activity for basophil histamine release corresponds with reductions in early skin responses i. British Society of Allergy and Clinical Immunology, Loughborough, UK, July, 2006.

Martins SB, Parrish D, Das AK, Shankar R, O’Connor MJ (2006). Towards semantic interoperability in a clinical trials management system. Fifth International Seman-tic Web Conference (ISWC 2006), Athens, GA, Nov 5-9, 2006.

Shankar RD, Martins SB, O'Connor MJ, Parrish DB, Das AK (2006). A Knowledge-Based System for Managing Clinical Trials. 19th IEEE International Symposium on Computer-Based Medical Systems, Salt Lake City, Utah, June 22-23, 2006.

Shankar RD, O'Connor MJ, Parrish DB, Martins SB, Das AK (2006). Epoch: an Ontological Framework to Support Clinical Trials Management. International Workshop on Health Information and Knowledge Management (HIKM 2006), Arlington, VA, Nov 11, 2006.

Asare AL, Kolchinsky SA, Wood P, Seyfert-Margolis VL. (2005). Comparison of RNA Preparation Methods and Their Effect on Cytokine/Chemokine Gene Expression. (Abstract #Su1.60) 2005 Meeting of the Federation of Clinical Immunology Societies, Boston, MA, May 12-16, 2005.

Carreno MR, Ciancio G, Burke GW, Cirocco R, Mathew J, Jin Y, Miller J, Salman F, Esquenazi V. (2005). Precursor dendritic cell subsets in kidney allograft recipients after induction with alemtuzumab (C1H) vs Thymoglobulin. ASHI 31st Annual Meeting, Washington, DC, Oct 17-21, 2005.

Carreno M, Cirocco R, Mathew J, Ciancio G, Burke GW, Miller J, Esquenazi V. (2005). Careno-T regulatory cells after induction therapy with Campath-1H, vs Thymoglobulin vs Daclizumab in kidney transplant recipien. American Transplant Congress, Seattle, WA, May 21, 2005.

Casale TB, Kline JN, Busse WW, Ballas ZK, Mokhtarani M, Seyfert-Margolis V, Bateman K, Moss MH, Townley RG. (2005). Casale-Omalizumab pretreatment prevents allergic reactions due to rush immunotherapy (RIT). (Abstract #259) AAAAI Annual Meeting, San Antonio, TX, March 18-22, 2005.

Cirocco R, Mathew J, Esquenazi V, Miller J., Careno M, Valone T (2005). Cirocco-Increased production of the regulatory T-cell transcription factor Fox P-3m-RNA and CD4+CD25+ cells in Campath-1H and do. ASHI 31st Annual Meeting, Washington, DC, Oct 17-21, 2005.

Asare AL, Kolchinsky SA, Seyfert-Margolis VL., Collin F, Speed TP (2005). Collin-NUSE and RLE: Quality assessment of oligonucleotide microarray data to quantify systemic variation. (Abstract #Su2.110) 2005 Meeting of the Federation of Clinical Immunology Societies, Boston, MA, May 12-16, 2005.

Esquenazi V, Kleiner G, Burke GW, Ciancio G, Ricordi C, Garcia-Morales RO, Cirocco RE, Carreno MR, Kenyon NS, Tzakis AG, Shariatmadar S, Miller J. (2005). Garcia-Comparative chimerism levels in cadaver and living related donor whole bone marrow infused kidney recipients vs. a 2X ste. th Basic Science Symposium of the International Transplantation Society, La Baule, France, June 19-23, 2005.

Hernandez-Fuentes MP, Sagoo P, Jimenez E, Rovis F, Stevenson S, Warrens A, Lechler R. (2005). Hernandez0Immune Monitoring in Renal Transplantation. British Society of Immunology, Harrogate, UK, December, 2005.

Kawai T, Sachs DH, Spitzer T, Tolkoff-Rubin N, Delmonico F, Saidman S, Shaffer J, Williams W, Dey B, McAfee S, Ko D, Hertl M, Goes N, Wong W, Fishman JA, Colvin RB, Sykes M, Cosimi B. (2005). Kawai. (Abstract #1535) American Transplant Congress, Seattle, WA, May 21, 2005.

Khoury SJ, Viglietta V, Hafler D, Bourcier K, Buckle G, Guttmann C, Bikowski M, Rusche J, Landy H, McNally J, Jauregui K. (2005). Khoury-A Phase I Trial of CTLA4Ig Treatment in MS. (Abstract #S46.004) 57th Annual Meeting of the American Academy of Neurology, Miami Beach, FL, April 9-15, 2005.

Kline JN, Casale TB, Busse WW, Ballas ZK, Mokhtarani M, Seyfert-Margolis V, Asare A, Bateman K, Moss MH, Bromstead C, Townley RG. (2005). Kline-Omalizumab Plus Rush Immunotherapy (RIT) Is More Effective Than RIT Alone In Preventing Ragweed-Induced Seasonal Allergic . (Abstract #827) 61st Annual Meeting of the American Academy of Allergy, Asthma and Immunology, San Antonio, TX, March 18-22, 2005.

Klunker S, Francis JN, Durham SR (2005). Klunker-Ragweed immunotherapy serum inhibits facilitated allergen presentation. 2005 Annual Meeting of the British Society for Allergy & Clinical Immunology, Loughborough, UK, July 18-20, 2005.

Herold KC, Gitelman SE, Liu WH, Szot G, Earle KE, Masharani U, Bluestone JA. (2005). Liu-Immune monitoring: the effects of hOKT3γ1 (Ala-Ala) in a patient with new onset type 1 diabetes mellitus. (Abstract #Su1.70) Meeting of the Federation of Clinical Immunology Societies, Boston, MA, May 12-16, 2005.

Vallone T, Carreno M, Rosen A, Gomez C, Garcia-Morales R, Blomberg B, Fuller L, Ciancio G, Esquenazi V, Miller J, Mathew JM, Burke G (2005). Mathew-Regulatory cell development in an LRD-kidney transplant recipient treated with alemtuzumab and donor stem cell infusions . ASHI 31st Annual Meeting, Washington, DC, Oct 17-21, 2005.

Offner H, Huan J, Bartholomew R, Bourdette D, Vandenbark A. (2005). Offner-Expression of the Treg cell associated Foxp3 gene is decreased in MS patients and increases following immunization with a. 5th Meeting of the European Neurological Society, Vienna, Austria, June 18-22, 2005.

Paraskevopoulos G, Jacobson MR, Till SJ, Francis JN, Carr V, Calderon M, Durham SR. (2005). Paraskevop-Grass pollen injection immunotherapy: Time course of suppression of allergen-induced late-phase skin responses. J Allergy Clin Immunology, 115, S266, 2005.

Raddassi K, Bourcier K, Estevam J, Hafler DA, Seyfert-Margolis V. (2005). Raddassi-Effect of freezing/thawing conditions and their optimization for quality control of PBMC viability and functional assay. (Abstract #Su1.106) 2005 Meeting of the Federation of Clinical Immunology Societies, Boston, MA, May 12-16, 2005.

Larché M, Shamji M, Wilcock L, Durham S, Francis J. (2005). Shamji-Analytical validation of a novel flow cytometric-based Facilitated Allergen Presentation (FAP) assay as a tool for monito. 2005 Annual Meeting of the British Society for Allergy & Clinical Immunology, Loughborough, UK, July 18-20, 2005.

Shankar R, O'Connor M, Martins S, Tu S, Parrish D, Musen M, Das A. (2005). Shamkar-A knowledge-driven approach to manage clinical trial protocols in the Immune Tolerance Network. American Medical Informatics Association Symposium, Unknown, October 25, 2005.

Huan J, Bartholomew R, Offner H, Vandenbark A, Bourdette D. (2005). Vandenbark-Decreased Foxp3 levels in MS patients are normalized by TCR peptide vaccination. 19th National Congress of the Polish Neurological Society, Lodz, Poland, Aug 31-Sept 3, 2005.

Vandenbark A, Huan J, Bartholomew R, Offner H, Bourdette D. (2005). Vandenbark-TCR peptide vaccination in MS induces high levels of IL-10 and restores decreased Foxp3 levels. ECTRIMS/ACTRIMS, Thessaloniki, Greece, Sept 28-Oct 1, 2005.

Wilcock LK, Wachholz PA, Klunker S, Francis JN, Durham SR, Na D H, Larsen JN (2005). Wilcock0Time-course of serum IgG4 levels and IgG inhibitory activity following withdrawal of grass pollen immunotherapy (IT). J Allergy Clin Immunology, 115, S265, 2005.

Dosch HM, Seyfert V, Greenbaum CJ, Gitelman SE, Palmer JP, Brooks-Worrell BM, Herold K (2004). BrooksWorrell-Marked Differences in T Cell Reactivity in Recently Diagnosed Type 1 Diabetes Patients Versus Controls. (Abstract #2778) XXIIth International Congress of Immunology, Montreal, Canada, July 18-23, 2004.

Casale TB (2004). Casale-Anti-IgE monoclonal antibody administered with immunotherapy. American College of Allergy, Asthma and Immunology (ACAAI), Boston, MA, Nov 4-9, 2004.

Casale TB (2004). Casale-Omalizumab And Immunotherapy. American College of Allergy, Asthma and Immunology (ACAAI), Boston, MA, Nov 4-9, 2004.

Eisenbarthh GS (2004). Eisenbarth-Autoantibodies in type 1 diabetes and neurological disorders.. XXIIth International Congress of Immunology, Montreal, Canada, July 18-23, 2004.

Fudaba Y, Shaffer JM, Kraus A, Cosimi AB, Delmonico FL, Dey B, Kawai T, McAfee S, Preffer F, Tolkoff-Rubin N, Sachs DH, Saidman Sl, Spitzer TR, Sykes M (2004). Fudaba-Alloresponses in tolerant recipients of combined kidney/bone marrow transplantation with non-myeloablative conditioning. (Abstract #P931) International Congress of Transplantation, Vienna, Austria, Sept 5-10, 2004.

Herold K, Gitelman S, Masharani U, Greenbaum C, Hagopian W, Gottlieb P, Muir A, Ramos E, Bluestone JA, Tomlin N (2004). Herold-Treatment with hOKT3γ1(Ala-Ala) improves insulin responses and reduces insulin requirements in patients with new onset Ty. (Abstract #1885) XXIIth International Congress of Immunology, Montreal, Canada, July 18-23, 2004.

Herold K, Gitelman S, Masharani U, Greenbaum C, Hagopian W, Gottlieb P, Ramos E, Bluestone JA, Muir A, Tomilin N (2004). Herold-ADA-Treatment with hOKT3γ1(Ala-Ala) improves insulin responses and reduces insulin requirements in patients with new onse. (Abstract #271-OR) 64th Scientific Sessions of the American Diabetes Association, Orlando, FL, June 4-8, 2004.

Kawai T, Sachs DH, Spitzer T, Sykes M, Tolkoff-Rubin N, Delmonico F, Saidman S, Shaffer J, Dey B, McAfee S, Williams W, Ko D, Hertl M, Goes N, Wong W, Colvin RB, Cosimi AB (2004). Kawai-20040Combined kidney and bone marrow transplantation for induction of mixed chimerism and renal allograft tolerance in HLA. (Abstract #1217) American Transplant Congress, Boston, MA, May 14-19, 2004.

Kawai T, Sachs DH, Spitzer T, Sykes M, Tolkoff-Rubin N, Delmonico F, Saidman S, Shaffer J, Dey B, McAfee S, Ko D, Wong W, Williams W, Goes N, Hertl M, Smith RN, Colvin RB, Cosimi AB (2004). Kawai0Combined kidney and bone marrow transplantation for induction of mixed chimerism and renal allograft tolerance in HLA mism. (Abstract #O112) 20th International Congress of the Transplantation Society, Vienna, Austria, September 5-10, 2004.

Khoury SJ, Bourcier K, Buckle G, Bikowski M, Guttmann C, Rioux P, Jauregui K (2004). Khoury-Phase I trial of CTLA4Ig treatment in MS.. (Abstract #S12.003) 56th American Academy of Neurology, San Francisco, CA, Aprli 24 - May 1, 2004.

Lakey JRT, Ricordi C, Hering B, DiMercurio B, Lindblad R, Olack B, Reems JA, Ansite J, Brandhorst H, Bertuzzi F, Berney T, Close N, Shapiro AMJ, Vivano L, O’Neil J (2004). Lakey-Standardization of Human Islet Isolation for a Multi-Center Transplant Trial.. (Abstract #P432) 20th International Congress of the Transplantation Society, Vienna, Austria, September 5-10, 2004.

Lakey JRT, Ricordi C, DiMercurio B, Lindblad R, Olack B, Reems JA, Ansite J, Bertuzzi F, Berney T, Viviano L, O'Neil J, Close N, Shapiro AMJ, Herring B, Brandhorst D (2004). Lakey-ADA-Standardization of human islet isolation procedures for a multicenter transplant trial.. 64th Scientific Sessions of the American Diabetes Association, Orlando, FL, June 4-8, 2004.

Mazariegos GV, Zahorchak A, Reyes J, Zeevi A, Chapman H, Girnita A, McDade K, Thompson A (2004). Mazariegos-Immunologic Assays in Patients Successfully Withdrawn from Immunosuppression (IS) after Liver Transplantation. (Abstract #521) American Transplant Congress, Boston, MA, May 14-19, 2004.

Parrish D, Raab M (2004). Parrish-Applying standard data warehousing approaches to biomedical data. BECON/BISTIC 2004 SYMPOSIUM - Biomedical Informatics for Clinical Decision Support: A Vision for the 21st Century, Bethesda, MD, June 21-22, 2004.

Shaffer JM, Kawai T, Fudaba Y, Cosimi AB, Saidman S, Preffer F, Delmonico F, McAfee S, Dey B, Spitzer TR, Sachs DH, Sykes M, Dombkowski D, Rubin-Tolkoff N (2004). Shaffer-Mechanisms of donor-specific unresponsiveness in tolerant recipient of combined non-myeloablative HLA-mismatched bone ma. (Abstract #526) American Transplant Congress, Boston, MA, May 14-19, 2004.

Shaffer J, Kawai T, Cosimi AB, Fudaba Y, Saidman S, Preffer F, Dombkowski D, Delmonico F, McAfee S, Tolkoff-Rubin N, Ballen K, Dey B, Spitzer TR, Sachs DH, Sykes M (2004). Shaffer-ICOT-Mechanisms of Donor-Specific Unresponsiveness in Tolerant Recipients of Combined Non-Myeloablative HLA-Mismatched. (Abstract #O36) 20th International Congress of the Transplantation Society, Vienna, Austria, September 5-10, 2004.

Shapiro AMJ, Ricordi C, Hering B, DiMercurio B, Lindblad R, Alejandro R, Cagliero E, Berney T, Secchi A, Brennan D, E, Viviano L, Ryan E, Lakey J, Brendal M, Robertson P, Ramos, Close N (2004). Shapiro-International Multi-Center Trial of Islet Transplantation Using the Edmonton Protocol in Patients with Type 1 Diabetes. (Abstract #O449) 20th International Congress of the Transplantation Society, Vienna, Austria, September 5-10, 2004.

Shapiro J, Ricordi C, Hering B, DiMercurio B, Lindblad R, Alejandro R, Cagliero E, Brendel M, Robertson P, Berney T, Secchi A, Brennan D, Ramos E, Viviano L, Ryan E, Close N, Lakey J (2004). Shapiro-ADA-International multi-center trial of islet transplantation using the Edmonton Protocol in patients with Type 1 diabet. (Abstract #1904-P) 64th Scientific Sessions of the American Diabetes Association, Orlando, FL, June 4-8, 2004.

Shapiro J, Ricordi C, Hering B, DiMercurio B, Lindblad R, Cagliero E, Brendel M, Robertson P, Berney T, Secchi A, Brennan D, Ramos E, Viviano L, Ryan E, Close N, Lakey J (2004). Shapiro-ATC-International multicenter trial of islet transplantation using the Edmonton protocol in patients with type 1 diabete. (Abstract #1434) American Transplant Congress, Boston, MA, May 14-19, 2004.

Vandenbark A, Bartholomew R, Bourdette D (2004). VandenbarkBoosting regulatory T-cells in multiple sclerosis: immunogenicity and safety of a trivalent BV5S2, BV6S5 and BV13S1 CD. II International Congress on Neuroimmunology, Venice, Italy, Sept 28 - Oct 4, 2004.

Vandenbark A, Bartholomew R, Bourdette D (2004). Vanden-Boosting regulatory T-cells in multiple sclerosis: immunogenicity and safety of a trivalent BV5S2, BV6S5 and BV13S1 CDR2 . 14th Meeting of the European Neurological Society, Barcelona, Spain, June 26-30, 2004.

Zhu S, Wong L, Hu D, Heinemeyer E, Huntsman S, Seyfert-Margolis V, Bluestone JA, Boden E, Chikuma S, Ye J (2004). Zhu-Comparison of new standard and amplification procedures with GeneChip arrays for studying T cell activation. (Abstract #471) XXIIth International Congress of Immunology, Montreal, Canada, July 18-23, 2004.

Anantharaman P, Dadhania D, Muthukumar T, Aull M, Seshan S, Hartono C, Serur D, Ding R, Li B, Suthanthiran M, Kapur S (2003). Anantharaman-Noninvasive surrogate for protocol biopsies of renal allografts and a mechanistic guide for the weaning of immunosu. (Abstract #1158) American Transplant Congress, Washington, DC, May 30 - Jun 4, 2003.

Dadhania D, Muthukumar T, Seshan S, Hartono C, Serur D, Ding R, Li B, Kapur S, Anantharaman P, Aull M, and Suthanthiran M (2003). Anantharaman-Measurement of mRNA for granzyme B in urine in the first week of renal transplantation predicts clinical as well as. (Abstract #1129) American Transplant Congress, Washington, DC, May 30 - Jun 4, 2003.

Creticos PS, Lighvani SS, Bieneman AP, Balcer-Whaley SP, Norman PS, Lichtenstein LM, Schroeder JY (2003). Enhanced IL10 Secretion by PBMC During the Ragweed Season: Effects of AIC Immunotherapy vs Placebo.. (Abstract #530) 60th Meeting of the AAAAI, Denver, CO, Mar 3-7, 2003.

Dadhania D, Muthukumar T, Anantharaman P, Ding R, Seshan S, Li B, Aull M, Hartono C, Serur D, Kapur S, Suthanthiran M (2003). Dadhania-mRNA profiles of urinary cells distinguish allograft infiltrates associated with acute rejection from infiltrates that . (Abstract #48) American Transplant Congress, Washington, DC, May 30 - Jun 4, 2003.

Fudaba Y, Kraus A, Cosimi AB, Dey B, Kawai T, McAfee S, Preffer F, Tolkoff-Rubin N, Sachs DH, Saidman Sl, Spitzer TR, Sykes M, Shaffer JM, Delmonico FL (2003). Fudaba-Alloresponses in tolerant recipients of combined kidney/bone marrow transplantation with non-myeloablative conditioning. (Abstract #640) American Transplant Congress, Washington, DC, May 30 - Jun 4, 2003.

Ricordi C, Hering B, DiMercurio B, Lindblad R, Bertuzzi F, Oberholzer J, Ramos E, Viviano L, Shapiro AMJ, Lakey JRT, O'Neil J, Olack B, Reems JA, Ansite J, Kirlew T, Brandhorst H, Bucher P (2003). Lakey-Standardization of human islet isolation for an international multi-center transplant trial. (Abstract #571) American Transplant Congress, Washington, DC, May 30 - Jun 4, 2003.

Mazariegos GV, Zeevi A, Flynn B, Logar AJ, Reyes J, Zahorchak A, Thomson A (2003). Mazariegos-Dendritic cell subsets in peripheral blood of patients successfully withdrawn from immunosuppression after liver tran. (Abstract #644) American Transplant Congress, Washington, DC, May 30 - Jun 4, 2003.

Ricordi C, DiMercurio B, Lindblad R, Cagliero E, Robertson RP, Berney T, Ramos E, Viviano L, Shapiro J, Hering B, Brendel M, Oberholzer J, Secchi A, Brennan D, Ryan E, Lakey J (2003). Shapiro-International multicenter trial of islet transplantation using the Edmonton protocol in patients with type 1 diabetes. (Abstract #3) American Transplant Congress, Washington, DC, May 30 - Jun 4, 2003.

Bluestone J, Zhu S, Hu D, Lyu SC, Wong L, Huntsman S, Heinemeyer E, Clayberger C (2003). Zhu-T cell activation kinetics from human peripheral blood lymphocytes (PBL) using Affymetrix GeneChip arrays.. FOCIS 2003 (Federation of Clinical Immunology Societies), Paris, France, May 15-19, 2003.

Zhu S, Hu D, Wong L, Huntsman S, Heinemeyer E, Bluestone J (2003). Zhu-Use of a low quantity of RNA for Affymetrix GeneChip arrays. Advanced Microarray Data Analysis, Bethesda, MD, Jan 20, 2003.

Creticos PS, Eiden JJ, Schroeder JT, Broide D H, Balcer-Whaley SL, Khattignavong A, Li H, Norman P, Hamilton R (2002). Immunotherapy with immunostimulatory oligonucleotides linked to purified ragweed amb a 1 allergen. 58th AAAAI, New York, NY, March 1-3, 2002.

Creticos PS, Eiden JJ, Balcer-Whaley SL, Schroeder JT, Khattignavong A, Li H, Norman P, Hamilton R, Broide DH (2002). Immunotherapy with Immunostimulatory Oligonucleotides Linked to Purified Ragweed Amb a 1 Allergen: Effects on Nasal Al. 24th Symposium of Collegium Internationale Allergoligicum, Bermuda, November 1, 2002.

Heeger PS, Tary-Lehmann M, Hricik DE, Gebrauer B, Schulak JA, Greenspan N (2002). Heeger -Post transplant immune monitoring by elispot reveals differences between patients with and without acute rejection. (Abstract #1067) American Transplant Congress, Washington, DC, Apr 25 - May 1, 2002.

Zeevi A, Reyes J, Thomson AW, Mazariegos G, Zahorchuk AF, Ostrowski L, Flynn B, Logar AJ, Dvorchik I (2002). Mazariegos- Myeloid pDC1 is decreased as compared to plasmacytoid pDC2 lineage in peripheral blood of patients successfully with. XIX Int'l Congress Transplantation, Miami, FL, Aug 25-30, 2002.

Seyfert-Margolis V (2002). Seyfert-Implication of genomics and proteomics for transplantation. XIX Int'l Congress Transplantation, Miami, FL, Aug 25-30, 2002.

Sykes M (2002). Sykes-Mixed chimerism: from bench to bedside. (Abstract #0631) XIX Int'l Congress Transplantation, Miami, FL, Aug 25-30, 2002.

Wood K (2002). Wood-Towards clinical tolerance: Regulatory Mechanisms. XIX Int'l Congress Transplantation, Miami, FL, Aug 25-30, 2002.

Review & Commentary

Renz H, Allen KJ, Sicherer SH, Sampson HA, Lack G, Beyer K, Oettgen HC (2018). Food allergy. Nat Rev Dis Primers, 4 (4), 17098. http://dx.doi.org/10.1038/nrdp.2017.98, PMID: 29300005

Newell KA, Turka LA, Adams AB (2018). Biomarkers of operational tolerance following kidney transplantation - The immune tolerance network studies of spontaneously tolerant kidney transplant recipients.. Hum Immunol., Published ahead of print. http://dx.doi.org/10.1016/j.humimm.2018.02.007, PMID: 29448053

Burks AW, Sampson HA, Plaut M, Lack G, Akdis C (2018). Treatment for food allergy. J Allergy Clin Immunol, 141 (1), 1-9. http://dx.doi.org/10.1016/j.jaci.2017.11.004, PMID: 29307409

Sampson HA, O'Mahony, L. Burks, AW. Plaut, M. Lack, G. Akdis, CA. (2018). Mechanisms of food allergy. J Allergy Clin Immunol, 141 (1), 11-19. http://dx.doi.org/10.1016/j.jaci.2017.11.005, PMID: 29307410

Sykes M (2018). Immune monitoring of transplant patients in transient mixed chimerism tolerance trials. Hum Immunol, 79 (5), 334-342. http://dx.doi.org/10.1016/j.humimm.2017.12.011, PMID: 29289741, PMCID: PMC5924718

Fisher HR, Du Toit G, Bahnson HT, Lack G (2018). The challenges of preventing food allergy: Lessons learned from LEAP and EAT. Ann Allergy Asthma Immunol, 121 (3), 313-319. http://dx.doi.org/10.1016/j.anai.2018.06.008, PMID: 29909054

Hemmings, O. Kwok, M. McKendry, R. Santos, AF. (2018). Basophil Activation Test: Old and New Applications in Allergy. Current Allergy and Asthma Reports, 18 (77). http://dx.doi.org/10.1007/s11882-018-0831-5, PMID: 30430289

Wang J, Lack G (2017). Food Allergy: Unmet Needs and New Perspectives. J Allergy Clin Immunol Pract, 5 (2), 295. http://dx.doi.org/10.1016/j.jaip.2017.01.002, PMID: 28283155

Bahnson HT, Du Toit G, Lack G (2017). Statistical Considerations of Food Allergy Prevention Studies. J Allergy Clin Immunol Pract, 5 (2), 274-82. http://dx.doi.org/10.1016/j.jaip.2016.12.007, PMID: 28283152

Nepom GT, Ramsey BW, Lonial S (2017). Academic, Foundation, and Industry Collaboration in Finding New Therapies. N Engl J Med, 376 (18), 1762-9. http://dx.doi.org/10.1056/NEJMra1612575, PMID: 28467868

Kean LS, Turka LA, Blazar BR (2017). Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy. Immunol Rev, 276 (1), 192-212. http://dx.doi.org/10.1111/imr.12523, PMID: 28258702, PMCID: PMC5338458

Lawson K, Bahnson HT, Sever M, Du Toit G, Lack G, Brittain E, Keet C, Greenhawt M, Fleischer D, Chan ES, Venter C, Stukus D, Gupta R, Spergel J (2017). Letter of response to Greenhawt et al. 'LEAPing Through the Looking Glass: Secondary Analysis of the Effect of Skin Test Size and Age of Introduction on Peanut Tolerance after Early Peanut Introduction'. Allergy, 72 (8), 1267-71. http://dx.doi.org/10.1111/all.13127, PMID: 28691223

Nepom GT, Scott D (2017). Looking behind the data curtain. Cell Immunol. http://dx.doi.org/10.1016/j.cellimm.2017.07.008, PMID: 28754194

Zuber J, Sykes M (2017). Mechanisms of Mixed Chimerism-Based Transplant Tolerance. Trends Immunol., 38 (11), 829-43. http://dx.doi.org/10.1016/j.it.2017.07.008, PMID: 28826941, PMCID: PMC5669809

Ehlers MR (2016). Immune Interventions to Preserve β Cell Function in Type 1 Diabetes. J Investig Med, 64 (1), 7-13. http://dx.doi.org/10.1097/JIM.0000000000000227, PMID: 26225763, PMCID: PMC4732932

Ehlers MR (2016). Strategies for clinical trials in type 1 diabetes. J Autoimmun, Jul (71), 88-96. http://dx.doi.org/10.1016/j.jaut.2016.03.008, PMID: 27068279, PMCID: PMC4903883

Buckner JH, Nepom GT (2016). Obstacles and opportunities for targeting the effector T cell response in type 1 diabetes. J Autoimmun, Jul (71), 44-50. http://dx.doi.org/10.1016/j.jaut.2016.02.009, PMID: 26948997, PMCID: PMC4903876

Asare AL, Carey VJ, Rotrosen D, Nepom GT (2016). Clinical trial data access: Opening doors with TrialShare. J Allergy Clin Immunol. http://dx.doi.org/10.1016/j.jaci.2016.05.034, PMID: 27474121

Du Toit G, Lack G, Tsakok T, Lack S (2016). Prevention of food allergy. J Allergy Clin Immunol, 137 (4), 998-1010. http://dx.doi.org/10.1016/j.jaci.2016.02.005, PMID: 27059727

Smilek DE; St Clair EW (2015). Solving the puzzle of autoimmunity: critical questions. F1000Prime Rep, 3 (7), 17. http://dx.doi.org/10.12703/P7-17, PMID: 25750735, PMCID: PMC4335798

McDonald-Hyman C, Turka LA, Blazar BR (2015). Advances and challenges in immunotherapy for solid organ and hematopoietic stem cell transplantation. Sci Transl Med, 7 (280), 280rv2. http://dx.doi.org/10.1126/scitranslmed.aaa6853., PMID: 25810312, PMCID: PMC4425354

Kimberly RP (2015). The Road Traveled: Genomics and Biomarkers in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Rheumatol, 67 (7), 1700-2. http://dx.doi.org/10.1002/art.39148, PMID: 25891203

Ehlers MR, Rigby MR (2015). Targeting Memory T Cells in Type 1 Diabetes. Curr Diab Rep, 15 (11), 84. http://dx.doi.org/10.1007/s11892-015-0659-5, PMID: 26370695

Newell KA, Turka LA (2015). Tolerance signatures in transplant recipients. Curr Opin Organ Transplant, 20 (4), 400-5. http://dx.doi.org/10.1097/MOT.0000000000000207, PMID: 26107969, PMCID: PMC4524570

Demetris AJ, Zeevi A, O'Leary JG (2015). ABO-compatible liver allograft antibody-mediated rejection: an update. Curr Opin Organ Transplant, 20 (3), 314-24. http://dx.doi.org/10.1097/MOT.0000000000000194, PMID: 25944231, PMCID: PMC4646419

Santos AF, Du Toit G, Lack G (2015). Is the use of epinephrine a good marker of severity of allergic reactions during oral food challenges?. J Allergy Clin Immunol Pract, 3 (3), 429-30. http://dx.doi.org/10.1016/j.jaip.2014.12.009, PMID: 25956314

Wofsy D, Diamond B, Houssiau FA (2015). Crossing the Atlantic: the Euro-Lupus Nephritis regimen in North America. Arthritis Rheumatol, 67 (5), 1144-6. http://dx.doi.org/10.1002/art.39067, PMID: 25779381, PMCID: PMC4523131

Kawai T, Leventhal J, Madsen JC, Strober S, Turka LA, Wood KJ (2014). Tolerance: one transplant for life. Transplantation, 98 (2), 117-121. http://dx.doi.org/10.1097/TP.0000000000000260, PMID: 24926829, PMCID: PMC4101034

Sykes M (2014). Transplantation: moving to the next level. Immunol Rev, 258 (1), 5-11. http://dx.doi.org/10.1111/imr.12161, PMID: 24517422, PMCID: PMC4038030

Ehlers MR (2014). Immune-modulating effects of alpha-1 antitrypsin. Biol Chem., 395 (10), 1187-93. http://dx.doi.org/10.1515/hsz-2014-0161, PMID: 24854541, PMCID: PMC4237306

Rigby MR, Ehlers MR (2014). Targeted immune interventions for type 1 diabetes: not as easy as it looks!. Curr Opin Endocrinol Diabetes Obes, 21 (4), 271-8. http://dx.doi.org/10.1097/MED.0000000000000075, PMID: 24983393, PMCID: PMC4133939

Smilek DE, Ehlers MR, Nepom GT (2014). Restoring the balance: immunotherapeutic combinations for autoimmune disease. Dis Model Mech, 7 (5), 503-13. http://dx.doi.org/10.1242/dmm.015099, PMID: 24795433, PMCID: PMC4007402

Nepom GT, Ehlers M, and Mandrup-Poulsen T (2013). Anti-cytokine therapies in T1D: Concepts and strategies. Clin Immunol, 14 (3), 279-285. http://dx.doi.org/10.1016/j.clim.2013.02.003, PMID: 23510726, PMCID: 3700624

Kawai T, Sachs DH (2013). Tolerance induction: hematopoietic chimerism. Curr Opin Organ Transplant, 18 (4), 402-407. http://dx.doi.org/10.1097/MOT.0b013e328363621d, PMID: 23838644

Demetris AJ, Isse K (2013). Tissue biopsy monitoring of operational tolerance in liver allograft recipients. Curr Opin Organ Transplant, 18 (3), 345-353. http://dx.doi.org/10.1097/MOT.0b013e3283615d48, PMID: 23619515

Tang Q, Bluestone JA (2013). Regulatory T-cell therapy in transplantation: moving to the clinic. Cold Spring Harb Perspect Med, 3 (11), na. http://dx.doi.org/10.1101/cshperspect.a015552, PMID: 24186492

Zarin D (2013). Participant-level data and the new frontier in trial transparency. N Engl J Med, 369 (5), 468-469. http://dx.doi.org/10.1056/NEJMe1307268, PMID: 23902488

Sosinowski T, Eisenbarth GS (2013). Type 1 diabetes: primary antigen/peptide/register/trimolecular complex. Immunol Res, 55 (1-3), 270-6. http://dx.doi.org/10.1007/s12026-012-8367-6, PMID: 22956469, PMCID: PMC3936464

Holt PG, Sly PD, Sampson HA, Robinson P, Loh R, Lowenstein H, Calatroni A, Sayre P (2013). Prophylactic use of sublingual allergen immunotherapy in high-risk children: a pilot study. J Allergy Clin Immunol., 132 (4), 991-3. http://dx.doi.org/10.1016/j.jaci.2013.04.049, PMID: 23768574

Kawai T, Sachs DH, Sykes M, Cosimi AB; Immune Tolerance Network (2013). HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med., 368 (19), 1850-2. http://dx.doi.org/10.1056/NEJMc1213779, PMID: 23656665, PMCID: PMC3760499

Tchao NK, Turka LA (2012). Lymphodepletion and homeostatic proliferation: Implications for transplantation. Am J Transplant, 12 (5), 1079-1090. http://dx.doi.org/10.1111/j.1600-6143.2012.04008.x, PMID: 22420320

Isse K, Lesniak A, Grama K, Roysam B, Minervini MI, Demetris AJ (2012). Digital transplantation pathology: combining whole slide imaging, multiplex staining and automated image analysis. Am J Transplant, 12 (1), 27-37. http://dx.doi.org/10.1111/j.1600-6143.2011.03797.x., PMID: 22053785, PMCID: 3627485

Pietropaolo M, Towns R, Eisenbarth GS (2012). Humoral autoimmunity in type 1 diabetes: prediction, significance, and detection of distinct disease subtypes. Cold Spring Harb Perspect Med, 2 (10), na. http://dx.doi.org/10.1101/cshperspect.a012831, PMID: 23028135, PMCID: PMC3475400

Eisenbarth GS (2012). Prevention of type 1A diabetes mellitus. Endocr Pract, 18 (5), 745-749. http://dx.doi.org/10.4158/EP12080.OR, PMID: 22548954

Ehlers MR, Nepom GT (2012). Immune-directed therapy for type 1 diabetes at the clinical level: the Immune Tolerance Network (ITN) experience. Rev Diabet Stud, 9 (4), 359-71. http://dx.doi.org/10.1900/RDS.2012.9.359, PMID: 23804273, PMCID: PMC3740703

Nepom GT, St. Clair EW, Turka LA (2011). Challenges in the pursuit of immune tolerance. Immunol Rev, 241 (1), 49-62. http://dx.doi.org/10.1111/j.1600-065X.2011.01003.x, PMID: 21488889, PMCID: 3092524

Newell KA, Phippard D, Turka LA (2011). Regulatory cells and cell signatures in clinical transplantation tolerance. Curr Opin Immunol, 23 (5), 655-659. http://dx.doi.org/10.1016/j.coi.2011.07.008, PMID: 21982510

Kawai T, Cosimi, Sachs DH (2011). Preclinical and clinical studies on the induction of renal allograft tolerance through transient mixed chimerism. Curr Opin Organ Transplant, 16 (4), 366-371. http://dx.doi.org/10.1097/MOT.0b013e3283484b2c, PMID: 21666482, PMCID: 3151013

Bluestone JA, Krensky AM, Turka LA, Rotrosen D, Matthews JB (2010). Ten years of the Immune Tolerance Network: an integrated clinical research organization. Sci Transl Med, 2 (19), 1-4. http://dx.doi.org/10.1126/scitranslmed.3000672, PMID: 20371484

Matthews JB, Staeva TP, Bernstein PL, Peakman M, von Herrath M, ITN/JDRF Type 1 Diabetes Combination Therapy Assessment Group (2010). Developing combination immunotherapies for type 1 diabetes: recommendations from the ITN-JDRF Type 1 Diabetes Combination Therapy Assessment Group. Clin Exp Immunol, 160 (2), 176-184. , PMID: 20629979, PMCID: 2857940

Turka LA, Wood K, Bluestone JA (2010). Bringing transplantation tolerance into the clinic: lessons from the ITN and RISET for the Establishment of Tolerance consortia. Curr Opin Organ Transplant, 15 (4), 441-448. http://dx.doi.org/10.1097/MOT.0b013e32833bd371, PMID: 20631613

Bluestone JA, Auchincloss H, Nepom GT, Rotrosen D, St. Clair EW, Turka LA (2010). Immune Tolerance Network at 10 years: Tolerance research at the bedside. Nat Rev Immunol, 10 (11), 797-803. http://dx.doi.org/10.1038/nri2869, PMID: 20972473

Isse K, Grama K, Abbott IM, Lesniak A, Lunz J, Lee WM, Specht S, Corbitt N, Mizuguchi Y, Roysam B, Demetris AJG (2010). Adding value to liver (and allograft) biopsy evaluation using a combination of multiplex quantum dot immunostaining, high-resolution whole-slide digital imaging, and automated image analysis. Clin Liver Dis, 14 (4), 669-685. http://dx.doi.org/10.1016/j.cld.2010.07.004, PMID: 21055689

Seyfert-Margolis V, Turka LA (2008). Marking a path to transplant tolerance. J Clin Invest, 118 (8), 2684-. http://dx.doi.org/10.1172/JCI36552, PMID: 18654643, PMCID: 2483691

St. Clair EW, Turka LA, Saxon A, Matthews JB, Sayegh MH, Eisenbarth GS, Bluestone J (2007). New reagents on the horizon for immune tolerance. Ann Rev Med, 58 (0), 329–46. , PMID: 16987079

Afzali B, Lechler RI, Hernandez-Fuentes MP (2007). Allorecognition and the alloresponse: clinical implications. Tissue Antigens, 69 (6), 545-56. , PMID: 17498264

Miao D, Yu L, Eisenbarth GS (2007). Role of autoantibodies in type 1 diabetes. Front Biosci, 12 (0), 1889-1898. , PMID: 17127428

Devendra D, Eisenbarth GS (2004). Interferon alpha--a potential link in the pathogenesis of viral-induced type 1 diabetes and autoimmunity. Clin Immunol, 111 (3), 225-33. , PMID: 15183143

Devendra D, Liu E, Eisenbarth GS (2004). Type 1 diabetes: recent developments. BMJ, 328 (7442), 750-754. , PMID: 15044291, PMCID: PMC381328

Eisenbarth GS, Gottlieb PA (2004). Autoimmune polyendocrine syndromes. New Engl J Med, 350 (20), 36-47. , PMID: 15141045

Eisenbarth G, Jasinski J (2004). Disease prevention with islet autoantigens. Endocrinol Metab Clin North Am, 33 (1), 59-74. , PMID: 15053895

Saxon, A (2004). What impact will the Immune Tolerance Network have on the future treatment of allergic diseases?. Clin Exp Allergy, 34 (11), 1657-1659. , PMID: 15544586

Matthews JB, Ramos E, Bluestone JA (2003). Clinical trials of transplant tolerance: slow but steady progress. Am J Transplant, 3 (7), 794-803. , PMID: 12814471

Nepom, GT (2003). MHC multimers: expanding the clinical toolkit. Clin Immunol, 106 (1), 1-4. , PMID: 12584043

Rotrosen D, Matthews JB, Bluestone JA (2002). The Immune Tolerance Network: a new paradigm for developing tolerance-inducing therapies. J Allergy Clin Immunol, 110 (1), 17-23. , PMID: 12110811

Bluestone JA, Matthews J (2001). The Immune Tolerance Network: tolerance at the crossroads. Philos Trans R Soc Lond B Biol Sci, 356 (1409), 773-6. , PMID: 11375080, PMCID: PMC1088464

Diamond B, Bluestone J, Wofsy D (2001). The Immune Tolerance Network and rheumatic disease: immune tolerance comes to the clinic. Arthritis Rheum, 44 (8), 1730-5. , PMID: 11508422

Bluestone JA, Matthews JB (2000). The Immune Tolerance Network--an NIH/JDF-supported initiative to bring tolerance research into the clinic: a major new resource for clinical immunologists. Clin Immunol, 96 (3), 171-3. , PMID: 10964534